adverseReaction,147ac314-1b2a-4c17-8c51-57cfe361b7fb,12/22/2011,5,ISMN,Isosorbide Mononitrate,,,
adverseReaction,61dee012-43af-0e9a-3843-9b9b91e022c4,3/21/2012,3,AZA,Azathioprine,,,
adverseReaction,050bd2a2-a125-721a-e366-255c5466f018,1/26/2012,5,BSP,bromsulphalein,,,
adverseReaction,740e054b-faac-7c27-f06d-a56efb699355,1/26/2012,5,BSP,bromsulphalein,,,
adverseReaction,d45fc842-2563-4421-86af-a55b3191e19b,1/9/2012,3,TZD,thiazolidinedione,,,
adverseReaction,c1ac4f63-695c-6bd6-4a7f-ecb97e03569e,3/7/2012,4,TZD,thiazolidinedione,,,
adverseReaction,ba48ac4b-9503-4006-f6e2-3b8a83059c03,12/16/2011,6,TZD,thiazolidinedione,,,
adverseReaction,b078dae2-664d-4144-847a-3b9d9b557402,1/27/2012,13,HCT,hydrochlorothiazide,,,
adverseReaction,539cdfb4-b920-48fb-8176-fe23841e3d32,2/14/2012,2,HCT,hydrochlorothiazide,,,
adverseReaction,ef08d90f-ba26-4b68-8e3a-d0320e4b0f8e,4/12/2012,2,ISMN,Isosorbide Mononitrate,,,
adverseReaction,c8b18a0b-b4f7-4f88-8732-1fa4736c3046,3/15/2012,3665,HCT,hydrochlorothiazide,,,
adverseReaction,ba5527fb-76fc-4ee5-b62e-a141c58c957d,1/17/2008,2,lorazepam,Lorazepam,,,
adverseReaction,F764D619-D2DD-4081-8467-DD2EC2AC68C3,1/24/2008,4,ddI,didanosine,,,
adverseReaction,eed26501-890d-4ff6-88e7-6dbea4726e53,6/27/2012,15,MMF,mycophenolate mofetil,,,
adverseReaction,21d9c619-7e94-49e2-ac41-31e9ea96554a,3/14/2012,6,ddI,didanosine,,,
adverseReaction,095081a0-1398-11dc-82e1-0002a5d5c51b,12/31/2011,8,NTG,nitroglycerin,,,
adverseReaction,095081a0-1398-11dc-82e1-0002a5d5c51b,12/31/2011,8,SNP,sodium nitroprusside,,,
adverseReaction,095081a0-1398-11dc-82e1-0002a5d5c51b,12/31/2011,8,NIC,nicardipine,,,
adverseReaction,96f11b5d-cc7b-48aa-830a-a28e1962d871,8/1/2011,8,GnRH,gonadotropin releasing hormone,,,
adverseReaction,03dc50f9-c7bd-4c0c-8bbb-c1216ec90c95,5/14/2007,1,DMA,Dimethylacetamide,,,
adverseReaction,A6CA918F-D031-4601-31A4-1848B580F2F0,8/7/2006,1,ddI,didanosine,,,
adverseReaction,A6CA918F-D031-4601-31A4-1848B580F2F0,8/7/2006,1,ZDV,zidovudine,,,
adverseReaction,9ac8b9fe-dfb9-0151-30b3-f9da72d74ac2,2/9/2012,10,HCTZ,hydrochlorothiazide,,,
adverseReaction,c7750b68-b3d8-45fa-b134-bf75f6ac510e,1/19/2010,2,HCTZ,hydrochlorothiazide,,,
boxedWarning,10E1D3EF-808E-47E4-A050-93A5918B1085,1/18/2008,3,DES,diethylstilbestrol,,,
boxedWarning,bd9a5180-1773-11e0-980a-0002a5d5c51b,2/16/2012,2,DMSO,dimethyl sulfoxide,,,
boxedWarning,86b90d68-bfb6-47f6-aa5b-a6642391ff13,6/3/2010,1,MPA,medroxyprogesterone acetate,,,
boxedWarning,EA3D70E5-DCCD-4302-964B-B5CB1394B514,7/25/2006,1,DES,diethylstilbestrol,,,
boxedWarning,36ec4df9-298d-4b15-9386-7848d217a46c,1/14/2010,2,MPA,medroxyprogesterone acetate,,,
boxedWarning,146f7be7-5cd4-4279-a482-794d0cd554e1,3/28/2006,1,Dantrium,dantrolene sodium,,,
clinicalPharmacology,26683db8-b319-4d67-8cd8-3c9803daa628,6/29/2010,2,DCT,demethylcitalopram,,,
clinicalPharmacology,26683db8-b319-4d67-8cd8-3c9803daa628,6/29/2010,2,DDCT,didemethylcitalopram,,,
clinicalPharmacology,26683db8-b319-4d67-8cd8-3c9803daa628,6/29/2010,2,CT,citalopram,,,
clinicalPharmacology,8a7a1fbf-652c-4c2a-8118-815341e8d2c1,4/30/2012,4,FSH,follicle stimulating hormone,,,
clinicalPharmacology,8a7a1fbf-652c-4c2a-8118-815341e8d2c1,4/30/2012,4,LH,luteinizing hormone,,,
clinicalPharmacology,7603f1ba-cfbd-4ec5-881a-13f4832c9893,5/6/2011,2,ACTH,adrenocorticotropic hormone,,,
clinicalPharmacology,68c5c707-4539-4ed9-ab12-4ac138c62ff3,1/7/2010,2,FSH,follicle stimulating hormone,,,
clinicalPharmacology,68c5c707-4539-4ed9-ab12-4ac138c62ff3,1/7/2010,2,LH,luteinizing hormone,,,
clinicalPharmacology,0a9d7dab-527d-429f-8590-16a32737fd58,12/31/2010,2,GABA,gamma-aminobutyric acid,,,
clinicalPharmacology,3942d30d-827b-46c7-8454-3020d5d7865d,7/9/2010,1,ODV,O-desmethylvenlafaxine,,,
clinicalPharmacology,b60a9829-f356-4e43-97d5-7666fe11588c,9/28/2010,42,mCPP,m-chlorophenylpiperazine,,,
clinicalPharmacology,833cd52c-6470-49c4-937f-1393971f4db9,9/1/2009,5,GX,glycinexylidide,,,
clinicalPharmacology,833cd52c-6470-49c4-937f-1393971f4db9,9/1/2009,5,MEGX,monoethylglycinexylidide,,,
clinicalPharmacology,9EAD5896-CF5F-7F3A-BD8D-BA6A7AEE930A,1/30/2009,1,GABA,gamma-aminobutyric acid,,,
clinicalPharmacology,DCC019EB-42F1-4A25-AF2A-6328B0FDB7D4,12/13/2006,1,MPA,medroxyprogesterone acetate,,,
clinicalPharmacology,DCC019EB-42F1-4A25-AF2A-6328B0FDB7D4,12/13/2006,1,FSH,follicle stimulating hormone,,,
clinicalPharmacology,DCC019EB-42F1-4A25-AF2A-6328B0FDB7D4,12/13/2006,1,LH,luteinizing hormone,,,
clinicalPharmacology,dbba2df7-6cb5-438f-bcde-6316f3fe10c8,2/23/2012,3,GABA,gamma-aminobutyric acid,,,
clinicalPharmacology,1a88218c-5b18-4220-8f56-526de1a276cd,11/1/2010,5,MPH,methylphenidate,,,
clinicalPharmacology,e84ca5ed-dff5-4a13-a04f-6aeee4be4bb0,5/21/2010,3,NMP,N-methylpyrrolidine,,,
clinicalPharmacology,1b87c5c3-6a4d-41f1-b504-60004366e613,6/1/2012,1,PABA,para-aminobenzoic acid,,,
clinicalPharmacology,A699724B-7412-479E-9894-4CF6EC454D8B,10/25/2007,6,mCPP,m-chlorophenylpiperazine,,,
clinicalPharmacology,7951139c-b271-45a4-b523-34b23800917b,4/27/2012,14,N-Ac-5-ASA,N-acetyl-5-aminosalicylic acid,,,
clinicalPharmacology,989705dd-929b-4b62-9ef4-e768f0e366cb,8/19/2010,1,ODV,O-desmethylvenlafaxine,,,
clinicalPharmacology,d3e5fbbf-4a1f-4aa2-8e80-9729f6cf04ee,4/14/2008,1,UFH,unfractionated heparin,,,
clinicalPharmacology,3b39a91e-f83c-45e3-bebc-a96078adc7f6,4/26/2011,1,DCT,demethylcitalopram,,,
clinicalPharmacology,3b39a91e-f83c-45e3-bebc-a96078adc7f6,4/26/2011,1,DDCT,didemethylcitalopram,,,
clinicalPharmacology,3b39a91e-f83c-45e3-bebc-a96078adc7f6,4/26/2011,1,GABA,gamma aminobutyric acid,,,
clinicalPharmacology,3b39a91e-f83c-45e3-bebc-a96078adc7f6,4/26/2011,1,CT,citalopram,,,
clinicalPharmacology,0376351b-f1a0-43e5-a0b4-533072c49f39,6/22/2012,4,HMG-CoA,3-hydroxy-3-methylglutaryl-coenzyme A,,,
clinicalPharmacology,57CEBFF0-1C66-4FD1-96EC-45AB7A4B801B,12/9/2008,2,FSH,follicle-stimulating hormone,,,
clinicalPharmacology,57CEBFF0-1C66-4FD1-96EC-45AB7A4B801B,12/9/2008,2,LH,luteinizing hormone,,,
clinicalPharmacology,D01C8FD1-25D4-49AB-8637-856843649B87,9/26/2008,1,GABA,gamma-aminobutyric acid,,,
clinicalPharmacology,57517a0e-ec1b-4605-a7cc-7e3801158ec9,6/21/2011,7,NMP,N-methylpyrrolidine,,,
clinicalPharmacology,4e45cd6c-a777-4100-943b-985058bff75a,2/2/2012,4,GX,glycinexylidide,,,
clinicalPharmacology,4e45cd6c-a777-4100-943b-985058bff75a,2/2/2012,4,MEGX,monoethylglycinexylidide,,,
clinicalPharmacology,71ba78cb-7e46-43eb-9425-fa130f537f84,5/8/2012,26,FSH,follicle stimulating hormone,,,
clinicalPharmacology,71ba78cb-7e46-43eb-9425-fa130f537f84,5/8/2012,26,LH,luteinizing hormone,,,
clinicalPharmacology,ff0b3cd5-c9cd-42df-b72f-4c69e76c7bd9,3/8/2010,1,PABA,para-aminobenzoic acid,,,
clinicalPharmacology,5ca97412-1594-4a4e-b5e4-8593ffa1b242,7/15/2011,2,GH,growth hormone,,,
clinicalPharmacology,EC09AB1C-52FA-4F41-BF65-A632DCE8F097,3/31/2007,1,ISDN,isosorbide dinitrate,,,
clinicalPharmacology,f1c40164-4626-4290-9012-c00e33420a33,2/25/2010,2,GX,glycinexylidide,,,
clinicalPharmacology,f1c40164-4626-4290-9012-c00e33420a33,2/25/2010,2,MEGX,monoethylglycinexylidide,,,
clinicalPharmacology,49f8ca7e-bedd-40b4-a31a-b1493b32c58b,12/16/2010,148,DCT,demethylcitalopram,,,
clinicalPharmacology,49f8ca7e-bedd-40b4-a31a-b1493b32c58b,12/16/2010,148,DDCT,didemethylcitalopram,,,
clinicalPharmacology,49f8ca7e-bedd-40b4-a31a-b1493b32c58b,12/16/2010,148,GABA,gamma aminobutyric acid,,,
clinicalPharmacology,49f8ca7e-bedd-40b4-a31a-b1493b32c58b,12/16/2010,148,DA,dopamine,,,
clinicalPharmacology,49f8ca7e-bedd-40b4-a31a-b1493b32c58b,12/16/2010,148,NE,norepinephrine,,,
clinicalPharmacology,e94c15f7-7115-4c9e-b5e5-6b8f275882a1,2/15/2012,2,MAOI,monoamine oxidase inhibitors,,,
clinicalPharmacology,e94c15f7-7115-4c9e-b5e5-6b8f275882a1,2/15/2012,2,IAA,indole acetic acid,,,
clinicalPharmacology,44ff9ecb-4c2b-4ac5-b2dc-5f6e83dbb2fd,7/8/2011,1,HMG-CoA,3-hydroxy-3-methylglutaryl-coenzyme A,,,
clinicalPharmacology,e7a2cbdd-1bdb-4e59-a3dd-298a189753ae,6/13/2012,7,DCT,demethylcitalopram,,,
clinicalPharmacology,e7a2cbdd-1bdb-4e59-a3dd-298a189753ae,6/13/2012,7,DDCT,didemethylcitalopram,,,
clinicalPharmacology,e7a2cbdd-1bdb-4e59-a3dd-298a189753ae,6/13/2012,7,GABA,gamma aminobutyric acid,,,
clinicalPharmacology,e7a2cbdd-1bdb-4e59-a3dd-298a189753ae,6/13/2012,7,CT,citalopram,,,
clinicalPharmacology,e7a2cbdd-1bdb-4e59-a3dd-298a189753ae,6/13/2012,7,DA,dopamine,,,
clinicalPharmacology,e7a2cbdd-1bdb-4e59-a3dd-298a189753ae,6/13/2012,7,NE,norepinephrine,,,
clinicalPharmacology,1AA8A109-8AB9-4CC6-A945-401FFDECD32E,2/26/2008,1,PABA,para-aminobenzoic acid,,,
clinicalPharmacology,e33ac27f-43ae-4912-8e41-626091fc5ad2,1/4/2012,4,FSH,follicle stimulating hormone,,,
clinicalPharmacology,e33ac27f-43ae-4912-8e41-626091fc5ad2,1/4/2012,4,LH,luteinizing hormone,,,
clinicalPharmacology,4a3f1deb-13b0-4253-b0af-7374880655d8,11/30/2009,3,MPH,methylphenidate,,,
clinicalPharmacology,82b5bf2c-7dc9-40bd-9fb4-b5b1b5be0470,9/10/2007,2,GX,glycinexylidide,,,
clinicalPharmacology,82b5bf2c-7dc9-40bd-9fb4-b5b1b5be0470,9/10/2007,2,MEGX,monoethylglycinexylidide,,,
clinicalPharmacology,6e8f7981-f2ca-4b56-8759-4f18cf9706c8,9/8/2010,3,BOH,beclomethasone,,,
clinicalPharmacology,be5f8ca6-7232-423a-a2d5-cccb7abe7921,12/8/2011,6,NMP,N-methylpyrrolidine,,,
clinicalPharmacology,e174c804-fe33-4cd8-809a-d107b5200064,12/29/2009,2,PIC,Polysaccharide iron complex,,,
clinicalPharmacology,AADEE2AB-113B-4CD4-8184-575C3F496990,1/8/2007,3,GABA,gamma-aminobutyric acid,,,
clinicalPharmacology,0FB7864F-BE1C-4992-A996-556AEF29981F,6/25/2008,2,GX,glycinexylidide,,,
clinicalPharmacology,0FB7864F-BE1C-4992-A996-556AEF29981F,6/25/2008,2,MEGX,monoethylglycinexylidide,,,
clinicalPharmacology,baf1bea8-c573-4ef8-8630-7b51a8e53cac,3/27/2009,1,ACh,acetylcholine,,,
clinicalPharmacology,a4ff77b8-04bc-4edb-a085-8d6d8687f8d1,8/17/2011,5,NET,norethindrone,,,
clinicalPharmacology,a4ff77b8-04bc-4edb-a085-8d6d8687f8d1,8/17/2011,5,HCTZ,hydrochlorothiazide,,,
clinicalPharmacology,a4ff77b8-04bc-4edb-a085-8d6d8687f8d1,8/17/2011,5,EE,ethinyl estradiol,,,
clinicalPharmacology,58e42210-291a-4f12-b6d3-5fbad7c5268b,8/9/2006,1,MPA,medroxyprogesterone acetate,,,
clinicalPharmacology,58e42210-291a-4f12-b6d3-5fbad7c5268b,8/9/2006,1,CE,conjugated estrogens,,,
clinicalPharmacology,58e42210-291a-4f12-b6d3-5fbad7c5268b,8/9/2006,1,FSH,follicle stimulating hormone,,,
clinicalPharmacology,58e42210-291a-4f12-b6d3-5fbad7c5268b,8/9/2006,1,LH,luteinizing hormone,,,
clinicalPharmacology,166abd26-675e-4832-9d18-0567f2a9d4e4,9/24/2010,1,ddI,didanosine,,,
clinicalPharmacology,eb558270-1b12-4704-9b09-39f668f30529,12/7/2010,1,AI,1-aminoindan,,,
clinicalPharmacology,6a73336d-216b-4070-bedc-f2c05bcc2d83,8/13/2010,350,GABA,gamma-aminobutyric acid,,,
clinicalPharmacology,c9e01766-a758-40dd-aa66-8cb24d77cd63,4/14/2011,4,HMG-CoA,3-hydroxy-3-methylglutaryl-coenzyme A,,,
clinicalPharmacology,483a42b9-c8f3-4f8b-98be-fcac5ab23c7c,5/18/2012,1,GABA,gamma-aminobutyric acid,,,
clinicalPharmacology,2471ee03-d747-4113-86d0-1aa93c8f3eba,2/9/2012,9,GABA,gamma-aminobutyric acid,,,
clinicalPharmacology,82174fcc-1b0f-2068-7fc4-db335b43b5e2,2/13/2012,14,FSH,follicle stimulating hormone,,,
clinicalPharmacology,82174fcc-1b0f-2068-7fc4-db335b43b5e2,2/13/2012,14,LH,luteinizing hormone,,,
clinicalPharmacology,2a1f280e-4edb-4726-844d-18ec19789152,11/7/2011,3,GABA,gamma-aminobutyric acid,,,
clinicalPharmacology,038ae416-4bd5-411b-bd28-d4f0af5c2ab7,5/16/2011,2,MPH,methylphenidate,,,
clinicalPharmacology,2ecc1f28-5673-4ba6-884d-b59d3167fe3b,7/22/2011,1,DCT,demethylcitalopram,,,
clinicalPharmacology,2ecc1f28-5673-4ba6-884d-b59d3167fe3b,7/22/2011,1,DDCT,didemethylcitalopram,,,
clinicalPharmacology,2ecc1f28-5673-4ba6-884d-b59d3167fe3b,7/22/2011,1,GABA,gamma aminobutyric acid,,,
clinicalPharmacology,2ecc1f28-5673-4ba6-884d-b59d3167fe3b,7/22/2011,1,CT,citalopram,,,
clinicalPharmacology,2ecc1f28-5673-4ba6-884d-b59d3167fe3b,7/22/2011,1,DA,dopamine,,,
clinicalPharmacology,2ecc1f28-5673-4ba6-884d-b59d3167fe3b,7/22/2011,1,NE,norepinephrine,,,
clinicalPharmacology,7dd162fc-f208-4746-b2da-92747fa2f3d5,8/17/2011,5,NET,norethindrone,,,
clinicalPharmacology,7dd162fc-f208-4746-b2da-92747fa2f3d5,8/17/2011,5,HCTZ,hydrochlorothiazide,,,
clinicalPharmacology,7dd162fc-f208-4746-b2da-92747fa2f3d5,8/17/2011,5,EE,ethinyl estradiol,,,
clinicalPharmacology,9df717ae-2d95-4ae3-bb5d-d1d285e15d26,5/21/2010,2,NMP,N-methylpyrrolidine,,,
clinicalPharmacology,b0e39608-a7ed-464a-91c9-867ad7cd293c,8/1/2011,9,GABA,gamma aminobutyric acid,,,
clinicalPharmacology,b0e39608-a7ed-464a-91c9-867ad7cd293c,8/1/2011,9,DA,dopamine,,,
clinicalPharmacology,b0e39608-a7ed-464a-91c9-867ad7cd293c,8/1/2011,9,NE,norepinephrine,,,
clinicalPharmacology,dca63476-c4a7-4857-84fe-7cb602e6393f,4/21/2011,2,Met,Metformin,,,
clinicalPharmacology,dca63476-c4a7-4857-84fe-7cb602e6393f,4/21/2011,2,Glyb,Glyburide,,,
clinicalPharmacology,57016639-89fe-43ad-89c4-5e7a756dddec,11/21/2011,1,NET,norethindrone,,,
clinicalPharmacology,57016639-89fe-43ad-89c4-5e7a756dddec,11/21/2011,1,HCTZ,hydrochlorothiazide,,,
clinicalPharmacology,57016639-89fe-43ad-89c4-5e7a756dddec,11/21/2011,1,EE,ethinyl estradiol,,,
clinicalPharmacology,774D9D1F-523B-4061-850A-00607DA15787,3/3/2008,2,DCT,demethylcitalopram,,,
clinicalPharmacology,774D9D1F-523B-4061-850A-00607DA15787,3/3/2008,2,DDCT,didemethylcitalopram,,,
clinicalPharmacology,774D9D1F-523B-4061-850A-00607DA15787,3/3/2008,2,GABA,gamma aminobutyric acid,,,
clinicalPharmacology,774D9D1F-523B-4061-850A-00607DA15787,3/3/2008,2,CT,citalopram,,,
clinicalPharmacology,774D9D1F-523B-4061-850A-00607DA15787,3/3/2008,2,DA,dopamine,,,
clinicalPharmacology,774D9D1F-523B-4061-850A-00607DA15787,3/3/2008,2,NE,norepinephrine,,,
clinicalPharmacology,0c9bcd9a-8e35-4b81-b088-630c124a51e9,5/17/2010,2,CE,conjugated estrogens,,,
clinicalPharmacology,bae7d458-01ce-423a-acae-40a834057103,6/1/2012,2,PIC,Polysaccharide iron complex,,,
clinicalPharmacology,dc548ff9-e8ea-4d6e-b9b4-e31f53ac4078,8/16/2010,6,GCV,ganciclovir,,,
clinicalPharmacology,dc548ff9-e8ea-4d6e-b9b4-e31f53ac4078,8/16/2010,6,VGCV,valganciclovir,,,
clinicalPharmacology,82c5998f-2253-4880-9be5-feaba553d5d1,5/10/2006,1,FSH,follicle-stimulating hormone,,,
clinicalPharmacology,82c5998f-2253-4880-9be5-feaba553d5d1,5/10/2006,1,LH,luteinizing hormone,,,
clinicalPharmacology,1c3ba0b0-0352-49e8-b5cd-9df698194988,3/31/2011,2,ddI,didanosine,,,
clinicalPharmacology,9e5b9309-e835-4863-ab6f-e3018e38fc64,12/31/2009,1,PIC,Polysaccharide iron complex,,,
clinicalPharmacology,3f3a870e-f325-475b-8453-fe3d1bb8f54a,3/19/2010,1,LH,luteinizing hormone,,,
clinicalPharmacology,1f1490cd-b11b-40cb-96be-865730c989e1,2/11/2008,2,BZ,benzodiazepine,,,
clinicalPharmacology,e2f53384-6c90-4a9f-aacf-281233581742,11/4/2010,1,PGE2,prostaglandin E2,,,
clinicalPharmacology,22fbf983-a490-42d6-b754-8b303409095c,3/31/2011,5,FSH,follicle stimulating hormone,,,
clinicalPharmacology,22fbf983-a490-42d6-b754-8b303409095c,3/31/2011,5,LH,luteinizing hormone,,,
clinicalPharmacology,c32ccd4d-77b4-4451-8c03-ffc6484bc1f3,4/15/2011,1,ODV,O-desmethylvenlafaxine,,,
clinicalPharmacology,32b48ea0-a215-43b8-83b4-a5435a686d68,8/1/2011,8,NET,norethindrone,,,
clinicalPharmacology,32b48ea0-a215-43b8-83b4-a5435a686d68,8/1/2011,8,HCTZ,hydrochlorothiazide,,,
clinicalPharmacology,32b48ea0-a215-43b8-83b4-a5435a686d68,8/1/2011,8,EE,ethinyl estradiol,,,
clinicalPharmacology,a6182855-6287-45e9-b6b4-7b57efc9c76e,4/6/2012,4,PABA,para-aminobenzoic acid,,,
clinicalPharmacology,4e07acff-27c2-4f5a-9d12-c9598496e9a0,11/19/2008,2,hCG,human chorionic gonadotropin,,,
clinicalPharmacology,14d06124-1eef-4f97-b1f3-18620819ae1a,6/26/2009,1,TFMA,4-trifluoromethylaniline,,,
clinicalPharmacology,fbf67fc8-8d29-4ae2-a533-75461754c5b1,3/14/2012,4,CBZ,Carbamazepine,,,
clinicalPharmacology,85d3ce8b-8966-45d9-bdaf-f6f0475096e1,11/23/2011,3,ODV,O-desmethylvenlafaxine,,,
clinicalPharmacology,151ffcf4-e503-4954-af7c-93d0a4f9f80e,12/15/2010,3,TFMA,4-trifluoromethylaniline,,,
clinicalPharmacology,A24DF8D2-E3EA-4224-AE4D-FFEB3E4BBDF1,5/15/2007,1,BZ,benzodiazepine,,,
clinicalPharmacology,175f2d9f-449b-4d95-a4b9-94f891f8e3ae,8/18/2011,2,PTZ,pentylenetetrazol,,,
clinicalPharmacology,175f2d9f-449b-4d95-a4b9-94f891f8e3ae,8/18/2011,2,GABA,gamma aminobutyric acid,,,
clinicalPharmacology,94d644b9-9ad1-4c21-9c88-c39796b3e3e6,10/27/2009,1,MAOI,monoamine oxidase inhibitors,,,
clinicalPharmacology,fcc8658c-761a-443f-8c32-1499d86028ec,5/11/2010,3,DEA,N-desethylamiodarone,,,
clinicalPharmacology,9c4136e8-c2dc-4ea0-9c65-f2d1c57d1171,11/15/2011,3165,GH,growth hormone,,,
clinicalPharmacology,9c4136e8-c2dc-4ea0-9c65-f2d1c57d1171,11/15/2011,3165,LH,luteinizing hormone,,,
clinicalPharmacology,b910cff4-22a4-4b39-b872-0bd1312f4d8b,3/17/2011,2,LH,luteinizing hormone,,,
clinicalPharmacology,b1d149db-ad43-4f3f-aef1-fb0395ba4191,12/24/2008,1,HO-NEF,hydroxynefazodone,,,
clinicalPharmacology,b1d149db-ad43-4f3f-aef1-fb0395ba4191,12/24/2008,1,mCPP,meta-chlorophenylpiperazine,,,
clinicalPharmacology,7bf48c44-6db5-434f-a60a-a41aed6dbc08,11/10/2011,3131,GABA,gamma-aminobutyric acid,,,
clinicalPharmacology,b89b5502-ce87-45a6-a43c-9891da3cfca4,3/28/2012,4,PABA,para-aminobenzoic acid,,,
clinicalPharmacology,e0990ade-320e-4259-8c0e-6d5ef23bc673,4/15/2011,1,ODV,O-desmethylvenlafaxine,,,
clinicalPharmacology,546130a3-e5f2-422d-88f0-66de19540ecb,1/19/2012,3,NET,norethindrone,,,
clinicalPharmacology,546130a3-e5f2-422d-88f0-66de19540ecb,1/19/2012,3,HCTZ,hydrochlorothiazide,,,
clinicalPharmacology,546130a3-e5f2-422d-88f0-66de19540ecb,1/19/2012,3,EE,ethinyl estradiol,,,
clinicalPharmacology,D59FA254-7959-47C9-BB77-AB7946A1A127,8/13/2008,1,ACh,acetylcholine,,,
clinicalPharmacology,b29fab7c-1282-4bb9-a650-24890501caec,12/1/2009,2,DCT,demethylcitalopram,,,
clinicalPharmacology,b29fab7c-1282-4bb9-a650-24890501caec,12/1/2009,2,DDCT,didemethylcitalopram,,,
clinicalPharmacology,b29fab7c-1282-4bb9-a650-24890501caec,12/1/2009,2,GABA,gamma aminobutyric acid,,,
clinicalPharmacology,b29fab7c-1282-4bb9-a650-24890501caec,12/1/2009,2,DA,dopamine,,,
clinicalPharmacology,b29fab7c-1282-4bb9-a650-24890501caec,12/1/2009,2,NE,norepinephrine,,,
clinicalPharmacology,53b73f2a-d839-41b5-bc9c-aeb3e9dba304,3/4/2012,9,ODV,O-desmethylvenlafaxine,,,
clinicalPharmacology,84f7c21f-d0af-4ae6-9cd5-d5af96ade329,12/10/2010,9,SAM,S-adenosylmethionine,,,
clinicalPharmacology,c135323a-33dd-49d5-b55a-33e1ff1b78fd,10/25/2010,2,PABA,para-aminobenzoic acid,,,
clinicalPharmacology,b4048138-3b43-4952-9c4d-f9278792f2b5,8/9/2011,1,ODV,O-desmethylvenlafaxine,,,
clinicalPharmacology,f18a82f7-ce44-4f9c-ae69-d3ad1d375564,11/8/2011,2,NTG,nitroglycerin,,,
clinicalPharmacology,32e2b197-e171-444d-86ca-198d4c84d7a5,11/23/2010,2,PABA,para-aminobenzoic acid,,,
clinicalPharmacology,5caff592-a90f-420d-a6ec-9b2dc914529e,1/20/2010,2,DCT,demethylcitalopram,,,
clinicalPharmacology,5caff592-a90f-420d-a6ec-9b2dc914529e,1/20/2010,2,DDCT,didemethylcitalopram,,,
clinicalPharmacology,5caff592-a90f-420d-a6ec-9b2dc914529e,1/20/2010,2,GABA,gamma aminobutyric acid,,,
clinicalPharmacology,5caff592-a90f-420d-a6ec-9b2dc914529e,1/20/2010,2,DA,dopamine,,,
clinicalPharmacology,5caff592-a90f-420d-a6ec-9b2dc914529e,1/20/2010,2,NE,norepinephrine,,,
clinicalPharmacology,21628112-0c47-11df-95b3-498d55d89593,1/18/2012,7,NET,norethindrone,,,
clinicalPharmacology,21628112-0c47-11df-95b3-498d55d89593,1/18/2012,7,HCTZ,hydrochlorothiazide,,,
clinicalPharmacology,21628112-0c47-11df-95b3-498d55d89593,1/18/2012,7,EE,ethinyl estradiol,,,
clinicalPharmacology,dbd47222-14f1-4588-a009-9b81b55ca60d,12/15/2011,4,GABA,gamma-aminobutyric acid,,,
clinicalPharmacology,f26ababe-f6f0-443e-8d91-4d2a174675bc,11/29/2011,1,GH,growth hormone,,,
clinicalPharmacology,f26ababe-f6f0-443e-8d91-4d2a174675bc,11/29/2011,1,LH,luteinizing hormone,,,
clinicalPharmacology,f26ababe-f6f0-443e-8d91-4d2a174675bc,11/29/2011,1,ACTH,adrenocorticotropic hormone,,,
clinicalPharmacology,65196e54-fde3-4977-b749-2d7aeed01ad4,3/31/2011,4,FSH,follicle stimulating hormone,,,
clinicalPharmacology,65196e54-fde3-4977-b749-2d7aeed01ad4,3/31/2011,4,LH,luteinizing hormone,,,
clinicalPharmacology,88c9d1ca-f3a8-4078-8de7-21fd9040dd20,2/14/2012,2,NET,norethindrone,,,
clinicalPharmacology,88c9d1ca-f3a8-4078-8de7-21fd9040dd20,2/14/2012,2,HCTZ,hydrochlorothiazide,,,
clinicalPharmacology,88c9d1ca-f3a8-4078-8de7-21fd9040dd20,2/14/2012,2,EE,ethinyl estradiol,,,
clinicalPharmacology,09BAFC2D-1893-4618-86DC-E9403407CD41,2/6/2006,1,FSH,follicle stimulating hormone,,,
clinicalPharmacology,09BAFC2D-1893-4618-86DC-E9403407CD41,2/6/2006,1,LH,luteinizing hormone,,,
clinicalPharmacology,5becda16-dd41-4ae0-ac40-013c5e07138e,12/7/2011,1,GABA,gamma-aminobutyric acid,,,
clinicalPharmacology,18e420b9-0fd1-48d9-9a23-c1e29a5f629f,2/1/2010,1,GX,glycinexylidide,,,
clinicalPharmacology,18e420b9-0fd1-48d9-9a23-c1e29a5f629f,2/1/2010,1,MEGX,monoethylglycinexylidide,,,
clinicalPharmacology,40c43d5a-7523-4ff1-863b-ed0c10a238f7,11/29/2011,2,FSH,follicle stimulating hormone,,,
clinicalPharmacology,40c43d5a-7523-4ff1-863b-ed0c10a238f7,11/29/2011,2,LH,luteinizing hormone,,,
clinicalPharmacology,f1a64637-6143-4543-a785-12e006cba849,5/17/2011,4,PABA,para-aminobenzoic acid,,,
clinicalPharmacology,08982e49-d2eb-4b25-b01a-1be52fd669ef,4/11/2012,7,TPV,Tipranavir,,,
clinicalPharmacology,706e938f-a0a0-42f6-b99b-60c31cbfb441,1/4/2006,1,GH,growth hormone,,,
clinicalPharmacology,706e938f-a0a0-42f6-b99b-60c31cbfb441,1/4/2006,1,LH,luteinizing hormone,,,
clinicalPharmacology,32266029-c710-44dd-943f-7e31d0afa622,6/4/2012,8,FSH,follicle-stimulating hormone,,,
clinicalPharmacology,32266029-c710-44dd-943f-7e31d0afa622,6/4/2012,8,LH,luteinizing hormone,,,
clinicalPharmacology,17e47845-daad-434c-a784-6d3875b0d704,7/15/2011,10,NAPA,N-acetylprocainamide,,,
clinicalPharmacology,67dcdd6e-48bc-418e-a887-805929d83ce0,10/14/2011,4,NET,norethindrone,,,
clinicalPharmacology,67dcdd6e-48bc-418e-a887-805929d83ce0,10/14/2011,4,HCTZ,hydrochlorothiazide,,,
clinicalPharmacology,67dcdd6e-48bc-418e-a887-805929d83ce0,10/14/2011,4,EE,ethinyl estradiol,,,
clinicalPharmacology,bf170659-a4f3-4ff7-8a0f-b3a0a2d02ff5,7/16/2012,3,FSH,follicle stimulating hormone,,,
clinicalPharmacology,bf170659-a4f3-4ff7-8a0f-b3a0a2d02ff5,7/16/2012,3,LH,luteinizing hormone,,,
clinicalPharmacology,a9415031-0643-42f6-a162-662433fc1071,5/29/2012,6,HMG-CoA,3-hydroxy-3-methylglutaryl-coenzyme A,,,
clinicalPharmacology,324a3791-d53e-4716-89cc-9516917407cf,6/21/2012,4,HMG-CoA,3-hydroxy-3-methylglutaryl-coenzyme A,,,
clinicalPharmacology,a747d8af-0d73-4c4a-b6b1-a254c75194f1,5/31/2011,1,FSH,follicle stimulating hormone,,,
clinicalPharmacology,a747d8af-0d73-4c4a-b6b1-a254c75194f1,5/31/2011,1,LH,luteinizing hormone,,,
clinicalPharmacology,D4EA84F2-A13F-4335-A184-1E87702BC396,7/13/2007,1,BZ,benzodiazepine,,,
clinicalPharmacology,b933c448-a7e5-4f38-b5e2-a03615826fa3,12/2/2011,4,TFMA,4-trifluoromethylaniline,,,
clinicalPharmacology,31392b3b-5d64-4a68-afab-4ef80704dd87,9/17/2010,393,LH,luteinizing hormone,,,
clinicalPharmacology,408eda31-0188-4f1d-96b9-8224dfe1bbc7,8/17/2009,1001,LH,luteinizing hormone,,,
clinicalPharmacology,7e7e03ba-5035-4e6d-9aa0-a00c8d3e0d87,11/17/2011,3,GX,glycinexylidide,,,
clinicalPharmacology,7e7e03ba-5035-4e6d-9aa0-a00c8d3e0d87,11/17/2011,3,MEGX,monoethylglycinexylidide,,,
clinicalPharmacology,03cdbf5b-b572-448f-80e9-b3e812959901,3/14/2012,2,MPA,medroxyprogesterone acetate,,,
clinicalPharmacology,03cdbf5b-b572-448f-80e9-b3e812959901,3/14/2012,2,CE,conjugated estrogens,,,
clinicalPharmacology,34c02bcc-d6ff-99d4-8e6a-4a91908adca8,7/30/2011,8,ddI,didanosine,,,
clinicalPharmacology,50603fd9-08fe-4bb7-80d2-1dd1e4aa4fcd,7/16/2012,2,MPA,medroxyprogesterone acetate,,,
clinicalPharmacology,50603fd9-08fe-4bb7-80d2-1dd1e4aa4fcd,7/16/2012,2,CE,conjugated estrogens,,,
clinicalPharmacology,92eafd85-0051-44af-ba5c-9194c8deffe2,12/19/2011,1,FSH,follicle stimulating hormone,,,
clinicalPharmacology,92eafd85-0051-44af-ba5c-9194c8deffe2,12/19/2011,1,LH,luteinizing hormone,,,
clinicalPharmacology,56e7180d-013d-4605-9444-66f7e857ba2c,10/6/2011,24,FSH,follicle stimulating hormone,,,
clinicalPharmacology,56e7180d-013d-4605-9444-66f7e857ba2c,10/6/2011,24,LH,luteinizing hormone,,,
clinicalPharmacology,e2f051ce-c4e4-43a1-9732-fe0a777a6951,10/20/2011,12,TFMA,4-trifluoromethylaniline,,,
clinicalPharmacology,753453c5-8a7a-878e-3ce7-1d1edce718a9,9/16/2011,2,TFMA,4-trifluoromethylaniline,,,
clinicalPharmacology,dbdee4c0-86fa-4857-b536-79bf9ebb911a,1/4/2010,2,HMG-CoA,3-hydroxy-3-methylglutaryl-coenzyme A,,,
clinicalPharmacology,dbdee4c0-86fa-4857-b536-79bf9ebb911a,1/4/2010,2,MNA,N-methylnicotinamide,,,
clinicalPharmacology,dbdee4c0-86fa-4857-b536-79bf9ebb911a,1/4/2010,2,2PY,N-methyl-2-pyridone-5-carboxamide,,,
clinicalPharmacology,dbdee4c0-86fa-4857-b536-79bf9ebb911a,1/4/2010,2,NUA,nicotinuric acid,,,
clinicalPharmacology,AE8F74F0-E600-4452-8557-958B603E2709,12/30/2008,1,ISDN,isosorbide dinitrate,,,
clinicalPharmacology,34B56F73-BEA4-4265-8B2A-C57520CF8E70,1/23/2008,1,hCG,human chorionic gonadotropin,,,
clinicalPharmacology,407e0758-9e2e-4e45-8c1b-10cfd2115b1f,3/15/2012,1,LV,leucovorin,,,
clinicalPharmacology,407e0758-9e2e-4e45-8c1b-10cfd2115b1f,3/15/2012,1,5-FU,5-fluorouracil,,,
clinicalPharmacology,10cc918f-aa44-415b-932d-2404695ac449,1/12/2010,1,ALOPRIM,allopurinol sodium,,,
clinicalPharmacology,cf64d0c0-7f1c-443d-93d5-1c41abb4e81d,3/22/2012,2,DCT,demethylcitalopram,,,
clinicalPharmacology,cf64d0c0-7f1c-443d-93d5-1c41abb4e81d,3/22/2012,2,DDCT,didemethylcitalopram,,,
clinicalPharmacology,cf64d0c0-7f1c-443d-93d5-1c41abb4e81d,3/22/2012,2,GABA,gamma aminobutyric acid,,,
clinicalPharmacology,cf64d0c0-7f1c-443d-93d5-1c41abb4e81d,3/22/2012,2,DA,dopamine,,,
clinicalPharmacology,cf64d0c0-7f1c-443d-93d5-1c41abb4e81d,3/22/2012,2,NE,norepinephrine,,,
clinicalPharmacology,4724dbb4-3613-4e6a-948f-a43d34f97f06,2/6/2012,9,HMG-CoA,3-hydroxy-3-methylglutaryl-coenzyme A,,,
clinicalPharmacology,1513b960-d9d1-11de-8a1e-0002a5d5c51b,10/5/2010,5,UFH,unfractionated heparin,,,
clinicalPharmacology,2DBA6C8E-3C51-4762-AE27-DCD760783F9B,11/5/2008,2,TFMA,4-trifluoromethylaniline,,,
clinicalPharmacology,75bf15c1-ffd8-46d3-8252-60b51e036794,7/25/2011,2,GABA,gamma aminobutyric acid,,,
clinicalPharmacology,75bf15c1-ffd8-46d3-8252-60b51e036794,7/25/2011,2,DA,dopamine,,,
clinicalPharmacology,75bf15c1-ffd8-46d3-8252-60b51e036794,7/25/2011,2,NE,norepinephrine,,,
clinicalPharmacology,9de97bb7-36e8-4126-bede-d48375da15df,12/21/2010,6,ODV,O-desmethylvenlafaxine,,,
clinicalPharmacology,BDDE7502-6218-401C-9A4F-DD3BC3A80F72,1/24/2008,1,HFIP,hexafluoroisopropanol,,,
clinicalPharmacology,22e635cb-98c0-e4f9-6a71-62d7487a0a6c,4/4/2011,7,GH,growth hormone,,,
clinicalPharmacology,22e635cb-98c0-e4f9-6a71-62d7487a0a6c,4/4/2011,7,LH,luteinizing hormone,,,
clinicalPharmacology,22e635cb-98c0-e4f9-6a71-62d7487a0a6c,4/4/2011,7,ACTH,adrenocorticotropic hormone,,,
clinicalPharmacology,AEC4204D-8A0C-443A-AAD1-1958DB28C60D,1/24/2008,1,DCT,demethylcitalopram,,,
clinicalPharmacology,AEC4204D-8A0C-443A-AAD1-1958DB28C60D,1/24/2008,1,DDCT,didemethylcitalopram,,,
clinicalPharmacology,AEC4204D-8A0C-443A-AAD1-1958DB28C60D,1/24/2008,1,GABA,gamma aminobutyric acid,,,
clinicalPharmacology,AEC4204D-8A0C-443A-AAD1-1958DB28C60D,1/24/2008,1,CT,citalopram,,,
clinicalPharmacology,AEC4204D-8A0C-443A-AAD1-1958DB28C60D,1/24/2008,1,DA,dopamine,,,
clinicalPharmacology,AEC4204D-8A0C-443A-AAD1-1958DB28C60D,1/24/2008,1,NE,norepinephrine,,,
clinicalPharmacology,AE0B595A-36D2-44F3-84F6-7FE9F995F4A1,5/9/2007,1,BZ,benzodiazepine,,,
clinicalPharmacology,6163F0B3-031B-4552-9299-B3F735762D24,11/17/2006,1,6-MP,6-mercaptopurine,,,
clinicalPharmacology,0d466214-78a8-44cd-923c-c286a0f74f66,3/23/2011,1,HMG-CoA,3-hydroxy-3-methylglutaryl-coenzyme A,,,
clinicalPharmacology,c6754623-b14c-4fc3-8719-48eee3119156,12/30/2011,3,DEO,N-desethyloxybutynin,,,
clinicalPharmacology,75a96561-6f52-4c11-a105-391fbbfe4827,10/3/2007,2,5-ASA,5-aminosalicylic acid,,,
clinicalPharmacology,25994fad-388d-4f9c-950e-14b7f8073b8c,1/14/2010,1,5-HMT,5-hydroxymethyl tolterodine,,,
clinicalPharmacology,e518dfc6-7e93-4fee-a66c-51e1ab71c056,10/31/2011,13,LV,leucovorin,,,
clinicalPharmacology,e518dfc6-7e93-4fee-a66c-51e1ab71c056,10/31/2011,13,5-FU,5-fluorouracil,,,
clinicalPharmacology,ba5d931f-5341-44cf-979c-a3df4f3cae3a,2/6/2012,3535,GABA,gamma-aminobutyric acid,,,
clinicalPharmacology,9a2b64bb-011a-4b23-b097-7dce576c57f8,10/12/2011,1,GABA,gamma-aminobutyric acid,,,
clinicalPharmacology,e38126a5-9d6a-422f-812c-a01610108162,3/23/2011,1,HMG-CoA,3-hydroxy-3-methylglutaryl-coenzyme A,,,
clinicalPharmacology,304d0be4-0c13-4dbb-8ffb-b2e7caa7fb1e,3/8/2012,1,DEA,N-desethylamiodarone,,,
clinicalPharmacology,f317cd06-2851-4a52-86d3-6efde3a4c243,10/22/2009,1,M6G,morphine-6-glucuronide,,,
clinicalPharmacology,f317cd06-2851-4a52-86d3-6efde3a4c243,10/22/2009,1,C6G,codeine-6-glucuronide,,,
clinicalPharmacology,f317cd06-2851-4a52-86d3-6efde3a4c243,10/22/2009,1,GH,growth hormone,,,
clinicalPharmacology,f317cd06-2851-4a52-86d3-6efde3a4c243,10/22/2009,1,LH,luteinizing hormone,,,
clinicalPharmacology,6f9d59e3-d10d-48f3-af01-83ba3e1e3a2b,11/30/2011,3,NET,norethindrone,,,
clinicalPharmacology,6f9d59e3-d10d-48f3-af01-83ba3e1e3a2b,11/30/2011,3,HCTZ,hydrochlorothiazide,,,
clinicalPharmacology,6f9d59e3-d10d-48f3-af01-83ba3e1e3a2b,11/30/2011,3,EE,ethinyl estradiol,,,
clinicalPharmacology,dd332944-d610-4338-9e5e-9b2e5e90e399,1/22/2010,1,MA,megestrol acetate,,,
clinicalPharmacology,e7e6da3b-8485-1382-61c9-e9b369018b98,9/1/2009,3,MPA,medroxyprogesterone acetate,,,
clinicalPharmacology,e7e6da3b-8485-1382-61c9-e9b369018b98,9/1/2009,3,CE,conjugated estrogens,,,
clinicalPharmacology,5abfea02-c3e4-4c09-8b4b-9159309ea6bf,10/17/2011,1,GABA,gamma-aminobutyric acid,,,
clinicalPharmacology,fcbea233-0aa2-462e-9254-7c970936e44c,6/23/2010,5,NET,norethindrone,,,
clinicalPharmacology,fcbea233-0aa2-462e-9254-7c970936e44c,6/23/2010,5,HCTZ,hydrochlorothiazide,,,
clinicalPharmacology,fcbea233-0aa2-462e-9254-7c970936e44c,6/23/2010,5,EE,ethinyl estradiol,,,
clinicalPharmacology,55889b3d-74c9-4638-9a14-6a4ca3a99f7f,3/2/2009,1,ODV,O-desmethylvenlafaxine,,,
clinicalPharmacology,7ab30afe-4de2-4fe5-9e62-a484683fb93f,7/21/2011,1,GX,glycinexylidide,,,
clinicalPharmacology,7ab30afe-4de2-4fe5-9e62-a484683fb93f,7/21/2011,1,MEGX,monoethylglycinexylidide,,,
clinicalPharmacology,38f42bad-6b2a-423d-af66-0e526ba03da1,4/28/2010,1,PABA,para-aminobenzoic acid,,,
clinicalPharmacology,202b1a2a-11dc-4c3d-aa53-27512a98a042,12/27/2010,1,NET,norethindrone,,,
clinicalPharmacology,202b1a2a-11dc-4c3d-aa53-27512a98a042,12/27/2010,1,HCTZ,hydrochlorothiazide,,,
clinicalPharmacology,202b1a2a-11dc-4c3d-aa53-27512a98a042,12/27/2010,1,EE,ethinyl estradiol,,,
clinicalPharmacology,B5C93AB1-317E-4F99-9EC5-E47B30FAF650,4/9/2009,1,TRH,Thyrotropin-releasing hormone,,,
clinicalPharmacology,e99d91ef-e189-4556-9343-5c8c9e1b6e1a,5/30/2012,3823,GABA,gamma-aminobutyric acid,,,
clinicalPharmacology,10124262-e443-49a5-a1cc-8cc34c74d953,11/29/2010,1,mCPP,m-chlorophenylpiperazine,,,
clinicalPharmacology,e38c7741-6d25-46d7-aeee-c14f7ee7aac3,11/29/2010,3,GX,glycinexylidide,,,
clinicalPharmacology,e38c7741-6d25-46d7-aeee-c14f7ee7aac3,11/29/2010,3,MEGX,monoethylglycinexylidide,,,
clinicalPharmacology,2bfb390f-ba99-4d21-8a9e-50fa8ec217c0,5/16/2011,1,MPH,methylphenidate,,,
clinicalPharmacology,e4886adf-199d-4b19-a4ef-75f8f94cb54e,10/19/2011,4,NET,norethindrone,,,
clinicalPharmacology,e4886adf-199d-4b19-a4ef-75f8f94cb54e,10/19/2011,4,HCTZ,hydrochlorothiazide,,,
clinicalPharmacology,e4886adf-199d-4b19-a4ef-75f8f94cb54e,10/19/2011,4,EE,ethinyl estradiol,,,
clinicalPharmacology,613768da-6140-4c11-affc-85ba8fe92018,5/21/2010,1,DCT,demethylcitalopram,,,
clinicalPharmacology,613768da-6140-4c11-affc-85ba8fe92018,5/21/2010,1,DDCT,didemethylcitalopram,,,
clinicalPharmacology,613768da-6140-4c11-affc-85ba8fe92018,5/21/2010,1,GABA,gamma aminobutyric acid,,,
clinicalPharmacology,613768da-6140-4c11-affc-85ba8fe92018,5/21/2010,1,DA,dopamine,,,
clinicalPharmacology,613768da-6140-4c11-affc-85ba8fe92018,5/21/2010,1,NE,norepinephrine,,,
clinicalPharmacology,f446e1b0-2c46-4763-8eb0-b3a6be956f69,3/7/2012,3,DEA,N-desethylamiodarone,,,
clinicalPharmacology,A0E521C3-7807-464E-922D-CE8F23216828,5/4/2007,1,BZ,benzodiazepine,,,
clinicalPharmacology,d19abf04-7723-9a14-e7f3-d992770e211e,11/11/2009,1,FSH,follicle stimulating hormone,,,
clinicalPharmacology,d19abf04-7723-9a14-e7f3-d992770e211e,11/11/2009,1,LH,luteinizing hormone,,,
clinicalPharmacology,7eeb2d81-c5d7-46a0-aa5c-149b55df71bd,11/4/2011,2,PTZ,pentylenetetrazol,,,
clinicalPharmacology,7eeb2d81-c5d7-46a0-aa5c-149b55df71bd,11/4/2011,2,GABA,gamma aminobutyric acid,,,
clinicalPharmacology,33bc102c-31a3-4fd9-9702-c1193d7699a3,10/27/2009,2,MA,megestrol acetate,,,
clinicalPharmacology,cdd50dc7-f712-4248-b0e3-ba247cf08cee,8/22/2011,10,DEA,N-desethylamiodarone,,,
clinicalPharmacology,83B78F99-DF2E-46C5-B308-03BAC56A8C8F,3/30/2007,3,MPA,medroxyprogesterone acetate,,,
clinicalPharmacology,0979fb90-9c22-4b74-8648-1174b905654d,3/19/2010,2,DCT,demethylcitalopram,,,
clinicalPharmacology,0979fb90-9c22-4b74-8648-1174b905654d,3/19/2010,2,DDCT,didemethylcitalopram,,,
clinicalPharmacology,0979fb90-9c22-4b74-8648-1174b905654d,3/19/2010,2,GABA,gamma aminobutyric acid,,,
clinicalPharmacology,0979fb90-9c22-4b74-8648-1174b905654d,3/19/2010,2,CT,citalopram,,,
clinicalPharmacology,0979fb90-9c22-4b74-8648-1174b905654d,3/19/2010,2,DA,dopamine,,,
clinicalPharmacology,0979fb90-9c22-4b74-8648-1174b905654d,3/19/2010,2,NE,norepinephrine,,,
clinicalPharmacology,a2f317f0-33ee-4298-bb5d-dd631d7bee25,10/15/2010,1,FSH,follicle stimulating hormone,,,
clinicalPharmacology,a2f317f0-33ee-4298-bb5d-dd631d7bee25,10/15/2010,1,LH,luteinizing hormone,,,
clinicalPharmacology,43934d82-cb79-467e-9092-23756406828b,7/13/2007,1,BZ,benzodiazepine,,,
clinicalPharmacology,b3eee508-8bf3-4bd3-9a71-47ee6ea87f95,3/2/2012,2,GX,glycinexylidide,,,
clinicalPharmacology,b3eee508-8bf3-4bd3-9a71-47ee6ea87f95,3/2/2012,2,MEGX,monoethylglycinexylidide,,,
clinicalPharmacology,7d060be3-1429-46c7-b312-d5727064eaaa,1/21/2009,1,GABA,gamma-aminobutyric acid,,,
clinicalPharmacology,4690d08b-767a-40e2-979d-76f1bc742c32,4/25/2011,3,NET,norethindrone,,,
clinicalPharmacology,4690d08b-767a-40e2-979d-76f1bc742c32,4/25/2011,3,HCTZ,hydrochlorothiazide,,,
clinicalPharmacology,4690d08b-767a-40e2-979d-76f1bc742c32,4/25/2011,3,EE,ethinyl estradiol,,,
clinicalPharmacology,b23637e5-d37f-41b5-ba76-fc053e903bc2,5/6/2011,6,ODV,O-desmethylvenlafaxine,,,
clinicalPharmacology,68d04ab4-19c6-4d74-b346-2fe96452b4ad,1/29/2007,1,TFMA,4-trifluoromethylaniline,,,
clinicalPharmacology,4bf994a4-6cc5-4941-8a81-6cf4c7ee235a,8/19/2010,359,GH,growth hormone,,,
clinicalPharmacology,b8004451-7b26-425b-b5ea-cbb1b08e30e3,6/1/2012,4,Met,Metformin Hydrochloride,,,
clinicalPharmacology,b8004451-7b26-425b-b5ea-cbb1b08e30e3,6/1/2012,4,Glyb,Glyburide,,,
clinicalPharmacology,8FBA17DA-573A-425B-B1D7-7DDEEEF3C957,6/3/2008,1,ODV,O-desmethylvenlafaxine,,,
clinicalPharmacology,89226149-47fa-4f7d-bb1f-1aa7034486b8,12/9/2011,3,ddI,didanosine,,,
clinicalPharmacology,099c0df0-098d-40d4-854e-3fb9b33e13d3,9/21/2011,1,GABA,gamma-aminobutyric acid,,,
clinicalPharmacology,13ca868d-a734-4c2f-88f0-ac1071ba7311,4/13/2010,1,ddI,didanosine,,,
clinicalPharmacology,0c3b40ab-0dd9-4e1c-a8bc-bf2b36066314,2/22/2012,7,FSH,follicle-stimulating hormone,,,
clinicalPharmacology,0c3b40ab-0dd9-4e1c-a8bc-bf2b36066314,2/22/2012,7,LH,luteinizing hormone,,,
clinicalPharmacology,89b6f044-fe14-4e38-b5ea-a3c525d29dd6,4/14/2010,1,ddI,didanosine,,,
clinicalPharmacology,08DF7DDD-2529-4B74-A3F2-8D5FC54E2BA0,9/16/2007,1,DCT,demethylcitalopram,,,
clinicalPharmacology,08DF7DDD-2529-4B74-A3F2-8D5FC54E2BA0,9/16/2007,1,DDCT,didemethylcitalopram,,,
clinicalPharmacology,08DF7DDD-2529-4B74-A3F2-8D5FC54E2BA0,9/16/2007,1,GABA,gamma aminobutyric acid,,,
clinicalPharmacology,08DF7DDD-2529-4B74-A3F2-8D5FC54E2BA0,9/16/2007,1,CT,citalopram,,,
clinicalPharmacology,08DF7DDD-2529-4B74-A3F2-8D5FC54E2BA0,9/16/2007,1,DA,dopamine,,,
clinicalPharmacology,08DF7DDD-2529-4B74-A3F2-8D5FC54E2BA0,9/16/2007,1,NE,norepinephrine,,,
clinicalPharmacology,b2503fff-c978-4efa-b1b4-d7740b6b26f2,3/6/2012,7,MAOI,monoamine oxidase inhibitors,,,
clinicalPharmacology,b2503fff-c978-4efa-b1b4-d7740b6b26f2,3/6/2012,7,IAA,indole acetic acid,,,
clinicalPharmacology,45fc03d1-cdba-4c96-a809-ae6703c2408b,5/16/2011,1,Glyb,Glyburide,,,
clinicalPharmacology,dd713e60-478c-43cd-b680-ff594a0b3864,10/16/2010,5,GABA,gamma-aminobutyric acid,,,
clinicalPharmacology,346af8fe-3816-49de-bfd3-5a7425e728f9,3/30/2007,1,GABA,gamma-aminobutyric acid,,,
clinicalPharmacology,e77eabc9-9f65-4d4b-8135-0290291e6ee8,5/22/2012,1,GABA,gamma-aminobutyric acid,,,
clinicalPharmacology,a6195532-388b-47f7-a984-89ed10e29bc6,3/26/2010,2,LH,luteinizing hormone,,,
clinicalPharmacology,b7fe7a71-a1bc-47a6-9377-3e515090d7f7,5/16/2011,1,DCT,demethylcitalopram,,,
clinicalPharmacology,b7fe7a71-a1bc-47a6-9377-3e515090d7f7,5/16/2011,1,DDCT,didemethylcitalopram,,,
clinicalPharmacology,b7fe7a71-a1bc-47a6-9377-3e515090d7f7,5/16/2011,1,GABA,gamma aminobutyric acid,,,
clinicalPharmacology,b7fe7a71-a1bc-47a6-9377-3e515090d7f7,5/16/2011,1,CT,citalopram,,,
clinicalPharmacology,b7fe7a71-a1bc-47a6-9377-3e515090d7f7,5/16/2011,1,DA,dopamine,,,
clinicalPharmacology,b7fe7a71-a1bc-47a6-9377-3e515090d7f7,5/16/2011,1,NE,norepinephrine,,,
clinicalPharmacology,A8DF90D8-78B3-48C3-B42E-1E651D81454B,3/4/2009,2,PABA,para-aminobenzoic acid,,,
clinicalPharmacology,f149569c-05d1-4dba-b35a-4ed6a633f776,8/18/2011,1,FSH,follicle-stimulating hormone,,,
clinicalPharmacology,f149569c-05d1-4dba-b35a-4ed6a633f776,8/18/2011,1,LH,luteinizing hormone,,,
clinicalPharmacology,d5d05b1f-9f45-4f66-9f75-3c67934105de,2/15/2012,2,N-Ac-5-ASA,N-acetyl-5-aminosalicylic acid,,,
clinicalPharmacology,4789c1dd-ae52-4962-be54-6ae7e08ac0e4,5/1/2007,1,PA,Procainamide,,,
clinicalPharmacology,4789c1dd-ae52-4962-be54-6ae7e08ac0e4,5/1/2007,1,NAPA,N-acetylprocainamide,,,
clinicalPharmacology,9378d186-5b25-49bc-8563-a659fa1194c2,2/24/2011,6,GX,glycinexylidide,,,
clinicalPharmacology,9378d186-5b25-49bc-8563-a659fa1194c2,2/24/2011,6,MEGX,monoethylglycinexylidide,,,
clinicalPharmacology,794aa355-66de-41b8-aedf-f2c40f6bc664,7/12/2012,11,GH,growth hormone,,,
clinicalPharmacology,794aa355-66de-41b8-aedf-f2c40f6bc664,7/12/2012,11,LH,luteinizing hormone,,,
clinicalPharmacology,012be6a1-42eb-478c-94c2-3326c40fbe72,11/23/2011,3252,HMG-CoA,3-hydroxy-3-methylglutaryl-coenzyme A,,,
clinicalPharmacology,f65ec19d-b90e-452e-b761-c68b1cf2c892,6/11/2012,8,GABA,gamma-aminobutyric acid,,,
clinicalPharmacology,36ec4df9-298d-4b15-9386-7848d217a46c,1/14/2010,2,MPA,medroxyprogesterone acetate,,,
clinicalPharmacology,36ec4df9-298d-4b15-9386-7848d217a46c,1/14/2010,2,FSH,follicle stimulating hormone,,,
clinicalPharmacology,36ec4df9-298d-4b15-9386-7848d217a46c,1/14/2010,2,LH,luteinizing hormone,,,
clinicalPharmacology,cb4f1002-9372-4fac-aea3-99142f93dd37,10/30/2009,1,CFCs,chlorofluorocarbons,,,
clinicalPharmacology,efd1106b-d369-4651-b703-b0985ce93b79,12/22/2011,3,NET,norethindrone,,,
clinicalPharmacology,efd1106b-d369-4651-b703-b0985ce93b79,12/22/2011,3,HCTZ,hydrochlorothiazide,,,
clinicalPharmacology,efd1106b-d369-4651-b703-b0985ce93b79,12/22/2011,3,EE,ethinyl estradiol,,,
clinicalPharmacology,b7e2af06-1fe4-4b45-ae5d-bc6279ca47f3,6/6/2012,1,DEA,N-desethylamiodarone,,,
clinicalPharmacology,1f0fa7d6-9309-4cf6-b842-3924ec8aebe7,12/6/2011,3320,ODV,O-desmethylvenlafaxine,,,
clinicalPharmacology,dfe97a3d-247d-4dda-a641-1a95196cd8d8,1/22/2010,1,M6G,morphine-6-glucuronide,,,
clinicalPharmacology,6ad768fe-10ec-47d5-9f98-4e396bc6aedb,5/26/2011,1,NMP,N-methylpyrrolidine,,,
clinicalPharmacology,c6fa0c7b-eea6-48f0-9ae9-c19eb088b271,9/7/2011,3,NET,norethindrone,,,
clinicalPharmacology,c6fa0c7b-eea6-48f0-9ae9-c19eb088b271,9/7/2011,3,HCTZ,hydrochlorothiazide,,,
clinicalPharmacology,c6fa0c7b-eea6-48f0-9ae9-c19eb088b271,9/7/2011,3,EE,ethinyl estradiol,,,
clinicalPharmacology,7a1e523a-b377-43dc-b231-7591c4c888ea,12/15/2011,4,CBZ,Carbamazepine,,,
clinicalPharmacology,786992bd-13a0-4a00-dfb2-6c135ecd349b,1/11/2011,5,ddI,didanosine,,,
clinicalPharmacology,1e9702c4-f2d7-4ea8-b6e8-7dca31671864,6/3/2009,4,MPA,medroxyprogesterone acetate,,,
clinicalPharmacology,1e9702c4-f2d7-4ea8-b6e8-7dca31671864,6/3/2009,4,CE,conjugated estrogens,,,
clinicalPharmacology,09be2cbc-73bf-4894-add6-10e46c4471c9,12/7/2011,3335,GX,glycinexylidide,,,
clinicalPharmacology,09be2cbc-73bf-4894-add6-10e46c4471c9,12/7/2011,3335,MEGX,monoethylglycinexylidide,,,
clinicalPharmacology,29c03bbf-2ab6-4de3-05ca-1e52d7c85a70,6/6/2011,1,FSH,follicle stimulating hormone,,,
clinicalPharmacology,29c03bbf-2ab6-4de3-05ca-1e52d7c85a70,6/6/2011,1,LH,luteinizing hormone,,,
clinicalPharmacology,ab02fb34-932c-43d6-a82c-9825957c6468,11/10/2011,3130,GABA,gamma-aminobutyric acid,,,
clinicalPharmacology,319F0AF7-6CC7-4A91-A28A-9CEEA37D0CA8,2/29/2008,1,FSH,follicle stimulating hormone,,,
clinicalPharmacology,319F0AF7-6CC7-4A91-A28A-9CEEA37D0CA8,2/29/2008,1,LH,luteinizing hormone,,,
clinicalPharmacology,C89D3ECC-4F4C-4566-8808-79152344194D,10/2/2008,1,NE,norepinephrine,,,
clinicalPharmacology,L51b031a0-bc40-4159-a434-d48c3eadd2ca,10/8/2006,1,PpIX,protoporphyrin IX,,,
clinicalPharmacology,FA122B5A-DDC3-A1B7-0DE3-FD0001FC8213,1/30/2009,1,GABA,gamma-aminobutyric acid,,,
clinicalPharmacology,d15c8f36-4dcc-4b28-b03c-4e81b2f9ad2e,1/4/2011,1,FSH,follicle stimulating hormone,,,
clinicalPharmacology,d15c8f36-4dcc-4b28-b03c-4e81b2f9ad2e,1/4/2011,1,LH,luteinizing hormone,,,
clinicalPharmacology,dba16dd8-5a2e-4914-a09d-2e4af18ee432,10/8/2010,2008,LH,luteinizing hormone,,,
clinicalPharmacology,1af94c80-2b17-409a-98f6-ce00f942351d,7/20/2012,5,NET,norethindrone,,,
clinicalPharmacology,1af94c80-2b17-409a-98f6-ce00f942351d,7/20/2012,5,HCTZ,hydrochlorothiazide,,,
clinicalPharmacology,1af94c80-2b17-409a-98f6-ce00f942351d,7/20/2012,5,EE,ethinyl estradiol,,,
clinicalPharmacology,fbfa1874-a710-49da-9e79-56cfaad69080,3/18/2010,1,LH,luteinizing hormone,,,
clinicalPharmacology,7d028b83-5166-4b2e-b442-ba6cbfefbfd6,1/31/2008,2,TRH,thyrotropin releasing hormone,,,
clinicalPharmacology,A9758BEA-B15B-42E5-938C-03E3F042B290,3/31/2007,1,FSH,follicle stimulating hormone,,,
clinicalPharmacology,A9758BEA-B15B-42E5-938C-03E3F042B290,3/31/2007,1,LH,luteinizing hormone,,,
clinicalPharmacology,a02a3bfc-8e79-4e59-953e-361f92a3b3f1,10/7/2011,17,NMP,N-methylpyrrolidine,,,
clinicalPharmacology,ffa97984-f7e1-4be6-a0fd-5998b18c42cd,10/8/2009,1,GABA,gamma-aminobutyric acid,,,
clinicalPharmacology,7140f8d9-e478-4f69-a4eb-3fd4c9414576,10/30/2009,2,FSH,follicle stimulating hormone,,,
clinicalPharmacology,7140f8d9-e478-4f69-a4eb-3fd4c9414576,10/30/2009,2,LH,luteinizing hormone,,,
clinicalPharmacology,2a9976e3-4595-4bc5-b7f9-f4a9bd59e55d,10/1/2010,1,GX,glycinexylidide,,,
clinicalPharmacology,2a9976e3-4595-4bc5-b7f9-f4a9bd59e55d,10/1/2010,1,MEGX,monoethylglycinexylidide,,,
clinicalPharmacology,cf73c385-5173-4b54-af23-069581c5d560,8/24/2010,1,CE,conjugated estrogens,,,
clinicalPharmacology,F764D619-D2DD-4081-8467-DD2EC2AC68C3,1/24/2008,4,MPEG,methoxypolyethylene glycol,,,
clinicalPharmacology,320f63f2-fac3-4aee-aff8-85724e00ef52,9/14/2010,6,TFMA,4-trifluoromethylaniline,,,
clinicalPharmacology,ACBCE0E8-5098-4785-943B-8BDB5FF17FAB,3/18/2008,1,GABA,gamma aminobutyric acid,,,
clinicalPharmacology,55be87b4-a69b-4bfd-bf92-2949ec5e5dab,10/5/2011,1,GX,glycinexylidide,,,
clinicalPharmacology,55be87b4-a69b-4bfd-bf92-2949ec5e5dab,10/5/2011,1,MEGX,monoethylglycinexylidide,,,
clinicalPharmacology,5ffefcdc-ebfa-4dc8-b484-719658da9d6d,5/24/2010,2,GX,glycinexylidide,,,
clinicalPharmacology,5ffefcdc-ebfa-4dc8-b484-719658da9d6d,5/24/2010,2,MEGX,monoethylglycinexylidide,,,
clinicalPharmacology,d3a4788f-6ff4-4804-9b41-7d6f0b27cd5c,8/11/2011,5,TFMA,4-trifluoromethylaniline,,,
clinicalPharmacology,793c9089-8139-4d21-9e8c-64eb0d554063,8/17/2011,1,DCT,demethylcitalopram,,,
clinicalPharmacology,793c9089-8139-4d21-9e8c-64eb0d554063,8/17/2011,1,DDCT,didemethylcitalopram,,,
clinicalPharmacology,793c9089-8139-4d21-9e8c-64eb0d554063,8/17/2011,1,GABA,gamma aminobutyric acid,,,
clinicalPharmacology,793c9089-8139-4d21-9e8c-64eb0d554063,8/17/2011,1,DA,dopamine,,,
clinicalPharmacology,793c9089-8139-4d21-9e8c-64eb0d554063,8/17/2011,1,NE,norepinephrine,,,
clinicalPharmacology,756e6ebc-36fa-b6ac-a228-9d86d0ab8256,9/1/2011,9,NET,norethindrone,,,
clinicalPharmacology,756e6ebc-36fa-b6ac-a228-9d86d0ab8256,9/1/2011,9,HCTZ,hydrochlorothiazide,,,
clinicalPharmacology,756e6ebc-36fa-b6ac-a228-9d86d0ab8256,9/1/2011,9,EE,ethinyl estradiol,,,
clinicalPharmacology,d93bc81a-650f-4070-beb4-3a5fa4d27a7d,8/1/2010,4,NMP,N-methylpyrrolidine,,,
clinicalPharmacology,d286d935-e409-452a-b7c2-84a446a6042b,4/9/2012,4,NET,norethindrone,,,
clinicalPharmacology,d286d935-e409-452a-b7c2-84a446a6042b,4/9/2012,4,HCTZ,hydrochlorothiazide,,,
clinicalPharmacology,d286d935-e409-452a-b7c2-84a446a6042b,4/9/2012,4,EE,ethinyl estradiol,,,
clinicalPharmacology,64ae46f5-889c-4c13-ab07-92bebe8d5ef2,10/27/2009,2,CE,conjugated estrogens,,,
clinicalPharmacology,04a413fe-95f4-47a7-42ac-283a9e78297d,4/27/2011,5,PAS,para-aminosalicylic acid,,,
clinicalPharmacology,cd288b01-b95c-6398-fdff-b9ead9f324fa,3/1/2012,11,MAOI,monoamine oxidase inhibitors,,,
clinicalPharmacology,cd288b01-b95c-6398-fdff-b9ead9f324fa,3/1/2012,11,IAA,indole acetic acid,,,
clinicalPharmacology,60f13170-9706-4f17-b890-44737c4d3a8d,12/19/2011,3395,LH,luteinizing hormone,,,
clinicalPharmacology,d52d231b-f407-f6a0-466e-0f714244010d,9/18/2009,1,L-dopa,levodopa,,,
clinicalPharmacology,284b5dac-2b8d-46bf-95fe-80ce03fa178a,11/23/2010,4,PABA,para-aminobenzoic acid,,,
clinicalPharmacology,28ae35c3-bce3-4a63-a4e4-085ffca92aef,9/30/2010,8,FSH,follicle stimulating hormone,,,
clinicalPharmacology,28ae35c3-bce3-4a63-a4e4-085ffca92aef,9/30/2010,8,LH,luteinizing hormone,,,
clinicalPharmacology,37992a25-68bd-4050-b936-596ddedc25a3,1/31/2009,1,PIC,Polysaccharide iron complex,,,
clinicalPharmacology,930601ae-c7bb-4ae1-8268-b87eee2bbe22,5/5/2010,1,GABA,gamma-aminobutyric acid,,,
clinicalPharmacology,3e029e9f-0db0-41b7-8552-4728da9bad78,10/15/2010,1,FSH,follicle stimulating hormone,,,
clinicalPharmacology,3e029e9f-0db0-41b7-8552-4728da9bad78,10/15/2010,1,LH,luteinizing hormone,,,
clinicalPharmacology,025fee85-53a8-4161-a806-44fd95d0ca74,12/31/2009,1,PIC,Polysaccharide iron complex,,,
clinicalPharmacology,b61c6a09-7764-4a92-93a9-a1356aeeaa9c,10/1/2010,1,GX,glycinexylidide,,,
clinicalPharmacology,b61c6a09-7764-4a92-93a9-a1356aeeaa9c,10/1/2010,1,MEGX,monoethylglycinexylidide,,,
clinicalPharmacology,4d78fba4-51af-472c-8b64-5505cb4b91dc,7/8/2011,1,NET,norethindrone,,,
clinicalPharmacology,4d78fba4-51af-472c-8b64-5505cb4b91dc,7/8/2011,1,HCTZ,hydrochlorothiazide,,,
clinicalPharmacology,4d78fba4-51af-472c-8b64-5505cb4b91dc,7/8/2011,1,EE,ethinyl estradiol,,,
clinicalPharmacology,C0403897-79F5-4086-94B7-56C0CB7EE65C,8/4/2007,3,ACTH,adrenocorticotropic hormone,,,
clinicalPharmacology,8debb03e-a237-4e0d-be06-8ae17eaa14fa,4/25/2012,1,GX,glycinexylidide,,,
clinicalPharmacology,8debb03e-a237-4e0d-be06-8ae17eaa14fa,4/25/2012,1,MEGX,monoethylglycinexylidide,,,
clinicalPharmacology,e057c25f-dfb3-419b-930b-7f272af400e5,11/23/2010,102,ODV,O-desmethylvenlafaxine,,,
clinicalPharmacology,f3637209-303e-4232-ae79-07315a990973,1/9/2012,1,ddI,didanosine,,,
clinicalPharmacology,341720f7-f76f-498b-856f-3d207ad63feb,1/30/2011,1,ODV,O-desmethylvenlafaxine,,,
clinicalPharmacology,35312f49-decf-428d-bf5f-4215b762ed3c,6/10/2011,7,NET,norethindrone,,,
clinicalPharmacology,35312f49-decf-428d-bf5f-4215b762ed3c,6/10/2011,7,HCTZ,hydrochlorothiazide,,,
clinicalPharmacology,35312f49-decf-428d-bf5f-4215b762ed3c,6/10/2011,7,EE,ethinyl estradiol,,,
clinicalPharmacology,32d6371e-ba56-4294-b732-6d43627c5c47,12/19/2011,18,NVP,nevirapine,,,
clinicalPharmacology,32d6371e-ba56-4294-b732-6d43627c5c47,12/19/2011,18,DLV,delavirdine,,,
clinicalPharmacology,cea5f748-3127-4d36-83af-9ab3cf58503c,1/18/2012,7,NET,norethindrone,,,
clinicalPharmacology,cea5f748-3127-4d36-83af-9ab3cf58503c,1/18/2012,7,HCTZ,hydrochlorothiazide,,,
clinicalPharmacology,cea5f748-3127-4d36-83af-9ab3cf58503c,1/18/2012,7,EE,ethinyl estradiol,,,
clinicalPharmacology,e9f89260-97fb-484a-af52-5d1be77fee76,5/24/2010,1,MAOI,monoamine oxidase inhibitors,,,
clinicalPharmacology,e26005ef-77f0-4393-a2dc-b5fe460cead8,12/4/2008,1,GABA,gamma-aminobutyric acid,,,
clinicalPharmacology,2e8f0889-57ca-498a-8e91-b8a24bbe47fd,5/31/2011,1,ODV,O-desmethylvenlafaxine,,,
clinicalPharmacology,bf82350e-9a31-47c6-bfd4-3b6a4713a730,2/10/2012,3553,LH,luteinizing hormone,,,
clinicalPharmacology,EF56C531-A1CA-B94C-23DE-A0BA617AE2B4,5/29/2007,1,BZ,benzodiazepine,,,
clinicalPharmacology,427cf924-be17-47dc-8f77-115fa2f3fe17,5/17/2012,10,FSH,follicle stimulating hormone,,,
clinicalPharmacology,427cf924-be17-47dc-8f77-115fa2f3fe17,5/17/2012,10,LH,luteinizing hormone,,,
clinicalPharmacology,d0e05816-ccf8-4008-b5de-4d3fbc3de3c1,2/1/2010,3,PCPZ,prochlorperazine,,,
clinicalPharmacology,cd4d1aeb-debf-458a-83c1-fa098d4d3415,4/29/2010,5,L-dopa,levodopa,,,
clinicalPharmacology,c3aeca7e-4b7d-431c-a0c9-f7f5b05ad5a8,8/5/2011,1,PABA,para-aminobenzoic acid,,,
clinicalPharmacology,f0b31daa-0792-43d5-af08-8b6a864dc90a,1/4/2010,1,FSH,follicle-stimulating hormone,,,
clinicalPharmacology,f0b31daa-0792-43d5-af08-8b6a864dc90a,1/4/2010,1,LH,luteinizing hormone,,,
clinicalPharmacology,7b666ef7-871d-403f-865a-4360c5ec61fd,12/13/2011,3375,GH,growth hormone,,,
clinicalPharmacology,f622616e-4c11-4149-bf00-5ea5ce97800b,4/9/2007,1,FSH,follicle-stimulating hormone,,,
clinicalPharmacology,f622616e-4c11-4149-bf00-5ea5ce97800b,4/9/2007,1,LH,luteinizing hormone,,,
clinicalPharmacology,c62ad12d-a7c1-4846-9dbf-6e11884000bc,12/17/2011,2,PABA,para-aminobenzoic acid,,,
clinicalPharmacology,2d5e70d8-9bf9-212c-63a4-44785f3fd015,11/21/1995,1,ddI,didanosine,,,
clinicalPharmacology,bcbdbb65-3d82-42e8-9564-630748549954,1/4/2012,3477,PABA,para-aminobenzoic acid,,,
clinicalPharmacology,12e68a18-813e-4645-b513-c64145bde969,8/4/2010,18,TRH,Thyrotropin-releasing hormone,,,
clinicalPharmacology,f2f20b37-8bd4-4e8a-b596-be80b48ca2f1,9/1/2011,3,LV,leucovorin,,,
clinicalPharmacology,f2f20b37-8bd4-4e8a-b596-be80b48ca2f1,9/1/2011,3,5-FU,5-fluorouracil,,,
clinicalPharmacology,6c96373f-6744-49d4-aec5-3720bc993fab,12/9/2010,2,DCT,demethylcitalopram,,,
clinicalPharmacology,6c96373f-6744-49d4-aec5-3720bc993fab,12/9/2010,2,DDCT,didemethylcitalopram,,,
clinicalPharmacology,6c96373f-6744-49d4-aec5-3720bc993fab,12/9/2010,2,GABA,gamma aminobutyric acid,,,
clinicalPharmacology,6c96373f-6744-49d4-aec5-3720bc993fab,12/9/2010,2,CT,citalopram,,,
clinicalPharmacology,51772745-9ea9-42cd-97e6-7266f41ae3ca,2/22/2011,1,DEA,N-desethylamiodarone,,,
clinicalPharmacology,05964DAE-8B84-467C-AF97-C82706A3CAD2,3/31/2007,1,SAM,S-adenosylmethionine,,,
clinicalPharmacology,e9108958-b8d7-4fba-87c3-9a32990de551,1/9/2012,2,DEA,N-desethylamiodarone,,,
clinicalPharmacology,fde9c9e4-5275-4aa5-8f56-56037b3db0c7,11/23/2011,1,FSH,follicle-stimulating hormone,,,
clinicalPharmacology,fde9c9e4-5275-4aa5-8f56-56037b3db0c7,11/23/2011,1,LH,luteinizing hormone,,,
clinicalPharmacology,1dc1ceb2-c0cc-4118-bd02-07145ccc7b09,2/8/2012,3544,GABA,gamma-aminobutyric acid,,,
clinicalPharmacology,20682605-557b-4586-9d98-829a63091ddf,1/20/2010,3,BOH,beclomethasone,,,
clinicalPharmacology,fea44910-400c-4688-bedc-bbb1615cd8f5,4/22/2010,1,PABA,para-aminobenzoic acid,,,
clinicalPharmacology,A274E3EA-BF67-4F81-AAA0-10475B20CD69,10/6/2006,1,5-HT,5-hydroxytryptamine,,,
clinicalPharmacology,C0FCB440-2C9F-4841-B164-5AB7168D81D9,3/16/2009,1,DCT,demethylcitalopram,,,
clinicalPharmacology,C0FCB440-2C9F-4841-B164-5AB7168D81D9,3/16/2009,1,DDCT,didemethylcitalopram,,,
clinicalPharmacology,C0FCB440-2C9F-4841-B164-5AB7168D81D9,3/16/2009,1,GABA,gamma aminobutyric acid,,,
clinicalPharmacology,C0FCB440-2C9F-4841-B164-5AB7168D81D9,3/16/2009,1,CT,citalopram,,,
clinicalPharmacology,C0FCB440-2C9F-4841-B164-5AB7168D81D9,3/16/2009,1,DA,dopamine,,,
clinicalPharmacology,C0FCB440-2C9F-4841-B164-5AB7168D81D9,3/16/2009,1,NE,norepinephrine,,,
clinicalPharmacology,c119ed19-5dc6-4c03-b705-2616c65ef041,9/30/2010,1,FSH,follicle stimulating hormone,,,
clinicalPharmacology,c119ed19-5dc6-4c03-b705-2616c65ef041,9/30/2010,1,LH,luteinizing hormone,,,
clinicalPharmacology,80f3b79c-a399-45b3-b755-8535457719af,6/19/2012,1,LV,leucovorin,,,
clinicalPharmacology,80f3b79c-a399-45b3-b755-8535457719af,6/19/2012,1,5-FU,5-fluorouracil,,,
clinicalPharmacology,fe6bfe6c-6350-43e0-aa9e-f2af8d1bf382,1/6/2012,2,PABA,para-aminobenzoic acid,,,
clinicalPharmacology,84AFE6C1-378C-4444-9D57-7444D8916ABA,8/2/2007,2,DCT,demethylcitalopram,,,
clinicalPharmacology,84AFE6C1-378C-4444-9D57-7444D8916ABA,8/2/2007,2,DDCT,didemethylcitalopram,,,
clinicalPharmacology,84AFE6C1-378C-4444-9D57-7444D8916ABA,8/2/2007,2,GABA,gamma aminobutyric acid,,,
clinicalPharmacology,84AFE6C1-378C-4444-9D57-7444D8916ABA,8/2/2007,2,CT,citalopram,,,
clinicalPharmacology,84AFE6C1-378C-4444-9D57-7444D8916ABA,8/2/2007,2,DA,dopamine,,,
clinicalPharmacology,84AFE6C1-378C-4444-9D57-7444D8916ABA,8/2/2007,2,NE,norepinephrine,,,
clinicalPharmacology,f63155b9-ea71-4a30-be32-37173f87bcbf,11/1/2010,1,MPH,methylphenidate,,,
clinicalPharmacology,2632b547-2e13-447f-ac85-c774e437d6a8,12/6/2010,9,DCT,demethylcitalopram,,,
clinicalPharmacology,2632b547-2e13-447f-ac85-c774e437d6a8,12/6/2010,9,DDCT,didemethylcitalopram,,,
clinicalPharmacology,2632b547-2e13-447f-ac85-c774e437d6a8,12/6/2010,9,GABA,gamma aminobutyric acid,,,
clinicalPharmacology,2632b547-2e13-447f-ac85-c774e437d6a8,12/6/2010,9,DA,dopamine,,,
clinicalPharmacology,2632b547-2e13-447f-ac85-c774e437d6a8,12/6/2010,9,NE,norepinephrine,,,
clinicalStudies,3275b824-3f82-4151-2ab2-0036a9ba0acc,6/15/2012,37,MMF,mycophenolate mofetil,,,
clinicalStudies,2e806747-b88b-49f6-9a72-5430ca4b31fb,7/23/2010,1,PCPZ,prochlorperazine,,,
clinicalStudies,222a28ca-70c3-474c-850e-fae39eaaf40f,11/16/2011,12,GH,growth hormone,,,
clinicalStudies,DCC019EB-42F1-4A25-AF2A-6328B0FDB7D4,12/13/2006,1,MPA,medroxyprogesterone acetate,,,
clinicalStudies,03226fdd-8be5-49a7-b63c-62f08e75cd2d,6/25/2012,6,PCPZ,prochlorperazine,,,
clinicalStudies,83B78F99-DF2E-46C5-B308-03BAC56A8C8F,3/30/2007,3,MPA,medroxyprogesterone acetate,,,
clinicalStudies,B7E8C9FB-75BC-0A1A-4523-4C0AB400E078,9/22/2008,1,MA,megestrol acetate,,,
clinicalStudies,2b01a50f-e517-4f6c-bee5-9925ff029e55,9/21/2011,12,Glyb,Glyburide,,,
clinicalStudies,75e4d917-e5c7-4c21-a782-808353dda907,5/4/2010,1,PCPZ,prochlorperazine,,,
clinicalStudies,02dc4c34-04e8-4f16-8109-b04d600a9c61,4/23/2012,3,PCPZ,prochlorperazine,,,
clinicalStudies,c9b74876-e665-442b-87ad-b7333bc9a67a,9/21/2009,2,MMC,mitomycin C,,,
clinicalStudies,2f082b68-dc74-418a-9e6f-b3c285b41d44,3/20/2012,3,DU,diazolidinyl urea,,,
clinicalStudies,2f082b68-dc74-418a-9e6f-b3c285b41d44,3/20/2012,3,PE,phenoxyethanol,,,
clinicalStudies,2f082b68-dc74-418a-9e6f-b3c285b41d44,3/20/2012,3,IMID,imidazolidinyl urea,,,
clinicalStudies,2f082b68-dc74-418a-9e6f-b3c285b41d44,3/20/2012,3,Q-15,Quaternium-15,,,
clinicalStudies,2f082b68-dc74-418a-9e6f-b3c285b41d44,3/20/2012,3,DB106,disperse blue 106,,,
clinicalStudies,2f082b68-dc74-418a-9e6f-b3c285b41d44,3/20/2012,3,BUD,budesonide,,,
clinicalStudies,4d0f0f1a-31af-40fa-9c64-e90891fa6ce4,6/15/2012,4,MP,methylprednisolone,,,
clinicalStudies,2D16F118-C185-4956-8A55-F0DBD5182B50,11/10/2008,3,ddI,didanosine,,,
clinicalStudies,2D16F118-C185-4956-8A55-F0DBD5182B50,11/10/2008,3,ZDV,zidovudine,,,
clinicalStudies,1e9702c4-f2d7-4ea8-b6e8-7dca31671864,6/3/2009,4,MPA,medroxyprogesterone acetate,,,
clinicalStudies,1e9702c4-f2d7-4ea8-b6e8-7dca31671864,6/3/2009,4,CE,conjugated estrogens,,,
clinicalStudies,025876b6-f031-43ea-967a-b1d95b4685a6,2/17/2012,2,ZDV,zidovudine,,,
clinicalStudies,7094279a-281a-4e53-ab2a-23fedb8c778a,1/27/2012,4,PCPZ,prochlorperazine,,,
clinicalStudies,4ac26ddd-b806-4168-aa82-e5a30145276d,11/19/2010,3,PCPZ,prochlorperazine,,,
clinicalStudies,4211fbea-7a8f-4300-b50e-e1aa58bb7c3f,9/8/2011,1,Glyb,Glyburide,,,
clinicalStudies,0f26220a-f4ab-4ceb-9a98-a13dbdeed81f,4/29/2011,1,MMF,mycophenolate mofetil,,,
clinicalStudies,63f7ac0f-51d7-4e9e-bc54-aee51183bbaa,8/8/2011,6,Glyb,Glyburide,,,
clinicalStudies,8206d0ce-030e-4eb0-a1b2-16aeda592112,2/11/2010,5,PCPZ,prochlorperazine,,,
clinicalStudies,508a406f-56cc-4032-99b9-0979fef6467a,8/10/2011,1,Glyb,Glyburide,,,
clinicalStudies,accf9569-4b57-4e83-a7db-4e890a75d1ba,6/19/2012,11,MP,methylprednisolone,,,
clinicalStudies,32d6371e-ba56-4294-b732-6d43627c5c47,12/19/2011,18,NFV,nelfinavir,,,
clinicalStudies,095081a0-1398-11dc-82e1-0002a5d5c51b,12/31/2011,8,NTG,nitroglycerin,,,
clinicalStudies,095081a0-1398-11dc-82e1-0002a5d5c51b,12/31/2011,8,SNP,sodium nitroprusside,,,
clinicalStudies,095081a0-1398-11dc-82e1-0002a5d5c51b,12/31/2011,8,NIC,nicardipine,,,
clinicalStudies,732834F2-E21F-4630-BEA8-AC5B41C8E1DA,8/31/2007,1,DNR,daunorubicin,,,
clinicalStudies,732834F2-E21F-4630-BEA8-AC5B41C8E1DA,8/31/2007,1,IDR,idarubicin,,,
clinicalStudies,165cff62-b284-4a27-a65d-9ec8a5bfcdd8,3/14/2012,12,ZDV,zidovudine,,,
clinicalStudies,0f85d6e4-35de-4e25-b4aa-af9a0ca24cf8,8/16/2011,7,MTZ,metronidazole,,,
clinicalStudies,0f85d6e4-35de-4e25-b4aa-af9a0ca24cf8,8/16/2011,7,BSS,bismuth subsalicylate,,,
clinicalStudies,0f85d6e4-35de-4e25-b4aa-af9a0ca24cf8,8/16/2011,7,TCN,tetracycline hydrochloride,,,
clinicalStudies,92eafd85-0051-44af-ba5c-9194c8deffe2,12/19/2011,1,MPA,medroxyprogesterone acetate,,,
clinicalStudies,0d7ec602-fd6a-4750-a5bf-d64b614391d5,6/14/2010,5,PCPZ,prochlorperazine,,,
clinicalStudies,a0a046c1-056d-45a9-bfd9-13b47c24f257,10/1/2011,15,6-MP,6-mercaptopurine,,,
clinicalStudies,34B56F73-BEA4-4265-8B2A-C57520CF8E70,1/23/2008,1,hCG,human chorionic gonadotropin,,,
clinicalStudies,b4c0128b-622c-42db-8e31-48c4ca6b1286,7/21/2011,2,Glyb,Glyburide,,,
clinicalStudies,4291b063-0b7d-468e-bae0-bc145e699ded,11/14/2011,1,Glyb,Glyburide,,,
contraindication,e7a2cbdd-1bdb-4e59-a3dd-298a189753ae,6/13/2012,7,MAOIs,monoamine oxidase inhibitors,,,
contraindication,7f144b68-ae90-483c-b030-f6824662a734,1/12/2012,1,MAOIs,monoamine oxidase inhibitors,,,
contraindication,11544DEA-2F5E-1536-584A-5D1F37A99770,3/27/2009,1,MAOI,monoamine oxidase inhibitor,,,
contraindication,08DF7DDD-2529-4B74-A3F2-8D5FC54E2BA0,9/16/2007,1,MAOIs,monoamine oxidase inhibitors,,,
contraindication,d8d5631c-7390-9500-b1b0-9544b378f2e9,8/17/2009,1,MAOI,monoamine oxidase inhibitor,,,
contraindication,1501000f-664d-42ef-bff0-f85a7996b11c,2/8/2012,1,MAOI,monoamine oxidase inhibitor,,,
contraindication,c32ccd4d-77b4-4451-8c03-ffc6484bc1f3,4/15/2011,1,MAOIs,monoamine oxidase inhibitors,,,
contraindication,82d793ee-4039-45fc-ac83-4bd5235f00aa,10/1/2011,1,MAOIs,monoamine oxidase inhibitors,,,
contraindication,10c0ed21-833a-4267-b388-56d0c1ebada8,7/12/2011,1,MAOI,monoamine oxidase inhibitor,,,
contraindication,85d3ce8b-8966-45d9-bdaf-f6f0475096e1,11/23/2011,3,MAOIs,monoamine oxidase inhibitors,,,
contraindication,3195db14-0cae-4b49-9fba-49b869fe92a8,3/23/2010,4,MAOI,monoamine oxidase inhibitor,,,
contraindication,1109d178-d4f5-432b-ad50-0d446bb53584,9/21/2011,1,MAOI,monoamine oxidase inhibitor,,,
contraindication,1292A04E-7220-4B2D-AE6F-334E1277000C,4/9/2008,1,MAOIs,monoamine oxidase inhibitors,,,
contraindication,326e8ab0-6886-4749-9544-885b37070051,3/30/2011,9,MAOIs,monoamine oxidase inhibitors,,,
contraindication,180A07FD-1F6A-4617-B8E0-F938C65BA273,10/10/2008,1,MAOI,monoamine oxidase inhibitor,,,
contraindication,27CAD186-5F47-49A6-AD75-DF3A38C1C614,1/31/2008,1,MAOIs,monoamine oxidase inhibitors,,,
contraindication,4A0AFC61-F83D-4871-86EB-929C9428A1E3,4/10/2008,1,MAOIs,monoamine oxidase inhibitors,,,
contraindication,dd6dda39-0e75-4a7a-bd6b-3fad3c462337,7/7/2011,1,MAOI,monoamine oxidase inhibitor,,,
contraindication,e5808712-4487-43b2-891f-e1ef47a9e28d,10/24/2011,1,MAOI,monoamine oxidase inhibitors,,,
contraindication,01800452-c353-4235-a66a-214048752e74,11/12/2009,6,MAOIs,monoamine oxidase inhibitors,,,
contraindication,33694be4-87ce-4d25-92f6-6ae517bdf5ff,11/2/2011,1,MAOIs,monoamine oxidase inhibitors,,,
contraindication,a4c012f0-50b6-42fb-9f06-a14632f23f2e,1/14/2011,5,MAOI,monoamine oxidase inhibitor,,,
contraindication,cb8c497a-4c4e-4af7-84d0-04c8c4636630,8/27/2007,2,MAOI,monoamine oxidase inhibitor,,,
contraindication,2c4cd6a8-b95a-4632-bbb8-c633a8561d43,3/14/2012,2,MAOIs,monoamine oxidase inhibitors,,,
contraindication,aa05d606-29fd-443e-802b-1d65584d6bb1,5/26/2011,4,MAOI,monoamine oxidase inhibitor,,,
contraindication,55889b3d-74c9-4638-9a14-6a4ca3a99f7f,3/2/2009,1,MAOIs,monoamine oxidase inhibitors,,,
contraindication,4a765347-d687-4af1-a33f-fbff972c6252,3/30/2011,1,MAOIs,monoamine oxidase inhibitors,,,
contraindication,74d9e09f-b9aa-42ee-b1b8-293dca821dcf,3/17/2008,1,MAOIs,monoamine oxidase inhibitors,,,
contraindication,0a580de2-95d2-49b6-a1e2-6daf70f1f8c8,5/29/2010,1,MAOIs,monoamine oxidase inhibitors,,,
contraindication,d0cda063-00c5-0921-ee39-d4de1381f91a,8/17/2009,1,MAOI,monoamine oxidase inhibitor,,,
contraindication,793c9089-8139-4d21-9e8c-64eb0d554063,8/17/2011,1,MAOIs,monoamine oxidase inhibitors,,,
contraindication,12016940-1156-44ce-b18d-eee811267eea,3/14/2012,2,MAOIs,monoamine oxidase inhibitors,,,
contraindication,86e4b89d-42df-463d-a740-8d0d06b75daa,7/22/2011,1,MAOI,monoamine oxidase inhibitor,,,
contraindication,1c7e1d55-e017-42c7-8ba2-b0ae266a2ba0,8/4/2011,1,MAOIs,monoamine oxidase inhibitors,,,
contraindication,9bc362d4-489c-4e7f-915a-3076ff8d132a,7/17/2012,2,MAOIs,monoamine oxidase inhibitors,,,
contraindication,255d0d9b-1253-4a33-8c9d-f4f168788d87,7/18/2011,1,MAOI,monoamine oxidase inhibitor,,,
contraindication,e0990ade-320e-4259-8c0e-6d5ef23bc673,4/15/2011,1,MAOIs,monoamine oxidase inhibitors,,,
contraindication,b29fab7c-1282-4bb9-a650-24890501caec,12/1/2009,2,MAOIs,monoamine oxidase inhibitors,,,
contraindication,142F9B27-65A7-4ADD-BDCC-2468695FEDFF,3/17/2009,4,MAOI,monoamine oxidase inhibitor,,,
contraindication,cf64d0c0-7f1c-443d-93d5-1c41abb4e81d,3/22/2012,2,MAOIs,monoamine oxidase inhibitors,,,
contraindication,39a85db1-9e59-4ab0-9e18-36757f019faa,6/13/2012,12,MAOIs,monoamine oxidase inhibitors,,,
contraindication,613768da-6140-4c11-affc-85ba8fe92018,5/21/2010,1,MAOIs,monoamine oxidase inhibitors,,,
contraindication,b0e39608-a7ed-464a-91c9-867ad7cd293c,8/1/2011,9,MAOIs,monoamine oxidase inhibitors,,,
contraindication,Lb6cc6969-daa0-4211-872a-05453cb33c70,3/5/2007,1,MAOIs,monoamine oxidase inhibitors,,,
contraindication,C7AB46CD-B3A0-3F9E-97E6-E6125E1A52A2,8/2/2007,1,MAOIs,monoamine oxidase inhibitors,,,
contraindication,af43f958-c8da-47c1-9227-443b6bfb281d,8/5/2011,1,MAOIs,monoamine oxidase inhibitors,,,
contraindication,3a8a4490-9243-4201-944d-cea27d3d69f5,8/1/2011,6,MAOI,monoamine oxidase inhibitor,,,
contraindication,A53538EB-FE22-4264-BFD7-63036B5D3D6C,12/23/2008,2,MAOI,monoamine oxidase inhibitor,,,
contraindication,87e10b06-773c-4d7b-97a7-34b2437c2b53,12/15/2010,2,MAOI,monoamine oxidase inhibitor,,,
contraindication,774D9D1F-523B-4061-850A-00607DA15787,3/3/2008,2,MAOI's,monoamine oxidase inhibitors,,,
contraindication,1dfbf901-c840-4e43-83ac-579ebe565ba3,8/4/2011,1,MAOI,monoamine oxidase inhibitor,,,
contraindication,0979fb90-9c22-4b74-8648-1174b905654d,3/19/2010,2,MAOIs,monoamine oxidase inhibitors,,,
contraindication,9f5a14c2-b460-402e-acb4-04402278e64b,11/2/2011,1,MAOIs,monoamine oxidase inhibitors,,,
contraindication,b8066438-9bf2-4417-87ce-f0c0975cf803,7/18/2011,1,MAOI,monoamine oxidase inhibitor,,,
contraindication,99400099-eae2-4061-a2c7-f56314973dc0,3/7/2012,2,MAOIs,monoamine oxidase inhibitors,,,
contraindication,C0FCB440-2C9F-4841-B164-5AB7168D81D9,3/16/2009,1,MAOIs,monoamine oxidase inhibitors,,,
contraindication,590CD4BB-C1BD-4CF1-893A-1E418621EED4,8/2/2007,2,MAOIs,monoamine oxidase inhibitors,,,
contraindication,A8B2AD71-CFDC-4A29-8194-DEEFEA138B16,5/16/2008,2,MAOIs,monoamine oxidase inhibitors,,,
contraindication,9ECC70DE-F89E-436C-9E7D-1B303C413E47,4/7/2008,3,MAOIs,monoamine oxidase inhibitors,,,
contraindication,18a9c172-7081-484a-8c3b-bde9b2e54e95,12/20/2011,2,MAOI,monoamine oxidase inhibitor,,,
contraindication,34efe868-f01a-49c7-ab02-9f659b1689f8,11/27/2007,6,MAOI,monoamine oxidase inhibitor,,,
contraindication,A69EC903-874E-4FEF-9E71-81E608DEB6A7,12/11/2008,1,MAOI,monoamine oxidase inhibitor,,,
contraindication,ba60c357-8e61-4a3d-b1dc-25602dbbfc2a,4/3/2012,1,MAOIs,monoamine oxidase inhibitors,,,
contraindication,F63868AF-7C5B-430A-81E7-2483286936F1,9/16/2007,1,MAOI,monoamine oxidase inhibitor,,,
contraindication,84AFE6C1-378C-4444-9D57-7444D8916ABA,8/2/2007,2,MAOIs,monoamine oxidase inhibitors,,,
contraindication,8FBA17DA-573A-425B-B1D7-7DDEEEF3C957,6/3/2008,1,MAOIs,monoamine oxidase inhibitors,,,
contraindication,63643535-0aa4-4cb3-870b-93933e48b9c1,10/25/2007,1,MAOIs,monoamine oxidase inhibitors,,,
contraindication,e077756b-af95-40e9-a65c-1b03012c855b,10/26/2011,1,MAOI,monoamine oxidase inhibitors,,,
contraindication,2e8f0889-57ca-498a-8e91-b8a24bbe47fd,5/31/2011,1,MAOIs,monoamine oxidase inhibitors,,,
contraindication,2632b547-2e13-447f-ac85-c774e437d6a8,12/6/2010,9,MAOIs,monoamine oxidase inhibitors,,,
contraindication,AB79AE6F-A8DC-4F6F-9093-D46902724669,10/10/2008,2,MAOI,monoamine oxidase inhibitor,,,
contraindication,07800675-f689-47d7-8203-073c797f7e21,10/18/2011,1,MAOI,monoamine oxidase inhibitors,,,
contraindication,AEC4204D-8A0C-443A-AAD1-1958DB28C60D,1/24/2008,1,MAOIs,monoamine oxidase inhibitors,,,
description,75a96561-6f52-4c11-a105-391fbbfe4827,10/3/2007,2,5-ASA,5-aminosalicylic acid,,,
description,22e92e0a-77ad-4128-8ea9-28766297026a,12/22/2010,1,PET,polyethylene terephthalate,,,
description,DC293A1C-995D-40FA-AC99-68DF12EB6D9E,10/23/2006,1,BHT,butylated hydroxytoluene,,,
description,DC293A1C-995D-40FA-AC99-68DF12EB6D9E,10/23/2006,1,BHA,butylated hydroxyanisole,,,
description,4e07acff-27c2-4f5a-9d12-c9598496e9a0,11/19/2008,2,LH,luteinizing hormone,,,
description,BB56DF52-5ABF-47DC-AB8D-902CFE19CCB2,2/25/2008,1,ALFENTA,alfentanil hydrochloride,,,
description,06c485cd-ee30-44f2-be63-bb98f8d1a907,1/15/2010,2,GTF,glucose tolerance factor,,,
description,fedfd1db-7e32-44b2-89e9-7bb00ee6810d,3/6/2012,6,PIFE,pentafluoroisopropenyl fluoromethyl ether,,,
description,27d36fbf-1892-48e1-a9b1-1625607ea516,7/12/2007,1,BHT,butylated hydroxytoluene,,,
description,b1d149db-ad43-4f3f-aef1-fb0395ba4191,12/24/2008,1,MAOI,monoamine oxidase inhibitors,,,
description,0376351b-f1a0-43e5-a0b4-533072c49f39,6/22/2012,4,HMG-CoA,3-hydroxy-3-methylglutaryl-coenzyme A,,,
description,37992a25-68bd-4050-b936-596ddedc25a3,1/31/2009,1,PIC,Polysaccharide iron complex,,,
description,025fee85-53a8-4161-a806-44fd95d0ca74,12/31/2009,1,PIC,Polysaccharide iron complex,,,
description,22700993-851a-48aa-941e-1d2b6b04081f,5/30/2012,1,HFIP,hexafluoroisopropanol,,,
description,b0172db6-fd8d-4ef3-873d-6c4de6538454,12/2/2011,7,DEHP,di-2-ethylhexylphthalate,,,
description,ea1b0dc1-bd3d-4762-9f27-4300e4606d3d,6/22/2012,3,PPA,Phenylpropanolamine hydrochloride,,,
description,545776FE-63DF-44AB-ACE3-F3D73D2E0092,5/11/2006,1,FLUOR-OP,fluorometholone ophthalmic suspension,,,
description,d45fc842-2563-4421-86af-a55b3191e19b,1/9/2012,3,PEG 400,polyethylene glycol 400,,,
description,ba60c357-8e61-4a3d-b1dc-25602dbbfc2a,4/3/2012,1,DMSO,dimethyl sulfoxide,,,
description,4C52C904-8137-4B10-8A85-D9B96C2D8A00,5/10/2006,1,oxine,oxyquinoline,,,
description,82b5bf2c-7dc9-40bd-9fb4-b5b1b5be0470,9/10/2007,2,PVP,polyvinylpyrrolidone,,,
description,9222a610-a6d9-4b06-8ea0-c23a9ba8e281,3/6/2012,1,BHT,butylated hydroxytoluene,,,
description,8d8aaac5-3203-4ade-ae74-e2ea469dae18,4/20/2011,1,BHT,butylated hydroxytoluene,,,
description,e174c804-fe33-4cd8-809a-d107b5200064,12/29/2009,2,PIC,Polysaccharide iron complex,,,
description,82d793ee-4039-45fc-ac83-4bd5235f00aa,10/1/2011,1,DMSO,dimethyl sulfoxide,,,
description,a9415031-0643-42f6-a162-662433fc1071,5/29/2012,6,HMG-CoA,3-hydroxy-3-methylglutaryl-coenzyme A,,,
description,324a3791-d53e-4716-89cc-9516917407cf,6/21/2012,4,HMG-CoA,3-hydroxy-3-methylglutaryl-coenzyme A,,,
description,AD3DA3C3-66B2-09FE-2C85-AAF4367E3732,10/6/2008,3,HMG-CoA,3-hydroxy-3-methylglutaryl-coenzyme A,,,
description,a2360c52-f2b3-43c6-8485-292d828a7488,6/9/2006,1,DEHP,di-2-ethylhexylphthalate,,,
description,c1ac4f63-695c-6bd6-4a7f-ecb97e03569e,3/7/2012,4,PEG 400,polyethylene glycol 400,,,
description,ba48ac4b-9503-4006-f6e2-3b8a83059c03,12/16/2011,6,PEG 400,polyethylene glycol 400,,,
description,ea8bf997-2c71-4014-b18d-4f7ab45dfa19,12/14/2011,4,HFIP,hexafluoroisopropanol,,,
description,42097235-FA5F-4052-A558-763116AFD58D,4/5/2007,1,tizanidine,Tizanidine hydrochloride,,,
description,c9aa6489-5a36-44ed-9512-b996833d82f7,5/4/2011,1405,HFIP,hexafluoroisopropanol,,,
description,9f84ea84-2d8b-4d91-a33f-7dfb5df937dc,7/24/2012,9,MMF,mycophenolate mofetil,,,
description,9f84ea84-2d8b-4d91-a33f-7dfb5df937dc,7/24/2012,9,MPA,mycophenolic acid,,,
description,e437efe0-9c6a-4f87-b3b4-de90443b095f,12/22/2006,2,DMSO,dimethylsulfoxide,,,
description,012be6a1-42eb-478c-94c2-3326c40fbe72,11/23/2011,3252,HMG-CoA,3-hydroxy-3-methylglutaryl-coenzyme A,,,
description,dbdee4c0-86fa-4857-b536-79bf9ebb911a,1/4/2010,2,HMG-CoA,3-hydroxy-3-methylglutaryl-coenzyme A,,,
description,34B56F73-BEA4-4265-8B2A-C57520CF8E70,1/23/2008,1,HMG-CoA,3-hydroxy-3-methylglutaryl-coenzyme A,,,
description,cb4f1002-9372-4fac-aea3-99142f93dd37,10/30/2009,1,CFCs,chlorofluorocarbons,,,
description,FAE013FC-E199-43F3-86EF-66D34017C534,5/11/2006,1,PGE2,prostaglandin E2,,,
description,4724dbb4-3613-4e6a-948f-a43d34f97f06,2/6/2012,9,HMG-CoA,3-hydroxy-3-methylglutaryl-coenzyme A,,,
description,20682605-557b-4586-9d98-829a63091ddf,1/20/2010,3,CFCs,chlorofluorocarbons,,,
description,0b2249cb-ecf4-4be9-a6b2-0fe6ca2a7a36,6/22/2012,3,PPA,Phenylpropanolamine hydrochloride,,,
description,089bde88-521a-401e-8f03-1320e7e6ae03,6/22/2012,3,PPA,Phenylpropanolamine hydrochloride,,,
description,e35aa027-aef2-485d-927c-ab350f51f977,2/16/2006,1,MEXITIL,mexiletine hydrochloride,,,
description,3dbab949-6ab7-4040-9c81-314e5bb61d41,3/7/2012,6,PIFE,pentafluoroisopropenyl fluoromethyl ether,,,
description,9e5b9309-e835-4863-ab6f-e3018e38fc64,12/31/2009,1,PIC,Polysaccharide iron complex,,,
description,4c6e76bc-c964-4955-e0a3-511d3386a9cc,5/2/2011,1409,HFIP,hexafluoroisopropanol,,,
description,BDDE7502-6218-401C-9A4F-DD3BC3A80F72,1/24/2008,1,HFIP,hexafluoroisopropanol,,,
dosage,1c12b44c-f074-4a14-efad-4a6c743613cf,7/9/2012,11,PVC,polyvinyl chloride,,,
dosage,cbd3396e-6b85-41bf-82d2-940beba86686,5/1/2012,2,PVC,polyvinyl chloride,,,
dosage,33770d80-754f-11de-8dba-0002a5d5c51b,4/25/2012,7,PET,polyethylene terephthalate,,,
dosage,1979fd2a-7e2b-4d9a-9286-1066a0da944c,8/19/2010,3,PET,polyethylene terephthalate,,,
dosage,304d0be4-0c13-4dbb-8ffb-b2e7caa7fb1e,3/8/2012,1,PVC,polyvinyl chloride,,,
dosage,d73713c3-3c48-4cce-8437-1723ca54d077,2/2/2010,2,PET,polyethylene terephthalate,,,
dosage,6c8d1720-4129-4d96-b037-b0b82b2d1f2e,7/5/2010,2,PET,polyethylene terephthalate,,,
dosage,f5a860f3-37ec-429c-ae04-9c88d7c55c08,7/23/2012,34,PVC,polyvinyl chloride,,,
dosage,13d36ab1-98c8-4672-8632-c6eb4922de40,12/7/2011,1,PET,polyethylene terephthalate,,,
dosage,fcc8658c-761a-443f-8c32-1499d86028ec,5/11/2010,3,PVC,polyvinyl chloride,,,
dosage,a002b40c-097d-47a5-957f-7a7b1807af7f,12/22/2011,130,MTX,methotrexate,,,
dosage,05c12da2-8814-4afd-bec0-30cf4cdd2b33,5/1/2012,9,PET,polyethylene terephthalate,,,
dosage,9fd7a181-ab26-4e68-8404-20ce339b0844,9/30/2010,2,PVC,polyvinyl chloride,,,
dosage,4c6a405d-d853-4ec4-94c4-3db5f2e99b08,10/11/2011,1,PET,polyethylene terephthalate,,,
dosage,f1ec6ac1-6b94-40bb-a329-9056f201090c,1/20/2012,1,PET,polyethylene terephthalate,,,
dosage,b91de288-ed7b-4b8d-b4d8-b84055bd501a,5/20/2010,1,PET,polyethylene terephthalate,,,
dosage,6044028a-26d0-4e48-9cfa-8d045c36661a,4/8/2011,1,PET,polyethylene terephthalate,,,
dosage,cdd50dc7-f712-4248-b0e3-ba247cf08cee,8/22/2011,10,PVC,polyvinyl chloride,,,
dosage,cae040bf-f379-49d5-b175-1da409832aff,2/16/2011,2,MTX,methotrexate,,,
dosage,d4b8a490-d96f-414e-b020-9460625c40ef,8/17/2011,1,PET,polyethylene terephthalate,,,
dosage,dd7f12a7-7fe5-470b-b151-6ccf19945638,8/3/2010,1,PET,polyethylene terephthalate,,,
dosage,a87d78b2-7170-4979-9291-1505bed2f3ca,2/20/2008,1,OND,ondansetron,,,
dosage,c7156e83-f344-4e9f-a42d-6dc8ce90a0b9,3/31/2011,1,METROGEL,metronidazole topical gel,,,
dosage,165703a0-16d0-b7ff-5b66-88f1f7fa0600,12/11/2009,2,PET,polyethylene terephthalate,,,
dosage,d59a23ba-9e28-42a3-8bfe-a3742fdfdebe,1/1/2011,1,PET,polyethylene terephthalate,,,
dosage,787c1115-61fa-41d1-a0b2-32318f1e20f5,8/1/2011,8,PET,polyethylene terephthalate,,,
dosage,d8d04647-8e25-4127-8ecf-360ce1991c2f,1/25/2012,1,PVC,polyvinyl chloride,,,
dosage,d41d6d19-086c-4e17-814c-6fd6f3e81e24,7/5/2010,2,PET,polyethylene terephthalate,,,
dosage,09e383a8-e912-4cf7-8fb3-05545af80dd0,9/30/2011,8,PET,polyethylene terephthalate,,,
dosage,2a6f5fe2-add6-4c6d-b07c-ce707bf49203,7/9/2012,5,PET,polyethylene terephthalate,,,
dosage,370faf80-e054-4b14-b4b3-a7b32d61a4ac,2/22/2012,3581,PET,polyethylene terephthalate,,,
dosage,18f1a4fc-dfca-4dde-8a11-f7e6d9e5656d,3/23/2012,6,PET,polyethylene terephthalate,,,
dosage,e9385674-c074-4854-9b5c-655846cd8e09,6/14/2012,8,PET,polyethylene terephthalate,,,
dosage,9186036e-589d-48a8-a1a8-2386bf553374,10/5/2011,1,PET,polyethylene terephthalate,,,
dosage,5cc4f6f0-8925-81e1-b210-b5a4509a25a9,12/11/2009,1,PET,polyethylene terephthalate,,,
dosage,51772745-9ea9-42cd-97e6-7266f41ae3ca,2/22/2011,1,PVC,polyvinyl chloride,,,
dosage,38e8f819-985c-4d20-aafd-3ba953af26ca,8/3/2010,6,PVC,polyvinyl chloride,,,
dosage,b7e2af06-1fe4-4b45-ae5d-bc6279ca47f3,6/6/2012,1,PVC,polyvinyl chloride,,,
dosage,60f0fb82-d870-4f07-82af-e4aeb79ed023,3/28/2007,1,PET,polyethylene terephthalate,,,
dosage,0e6364a4-6d66-4151-8197-d45e2a762895,1/11/2012,10,PET,polyethylene terephthalate,,,
dosage,F103B9F9-E081-419D-A2D8-B86ACDA834DD,6/30/2008,1,PET,polyethylene terephthalate,,,
dosage,8c07a4af-dd56-40e4-bd27-dcc0112f6f99,2/22/2012,3582,PET,polyethylene terephthalate,,,
dosage,608d4f0d-b19f-46d3-749a-7159aa5f933d,6/11/2012,1451,6-MP,6-mercaptopurine,,,
drugInteractions,1af94c80-2b17-409a-98f6-ce00f942351d,7/20/2012,5,NET,norethindrone,,,
drugInteractions,1af94c80-2b17-409a-98f6-ce00f942351d,7/20/2012,5,EE,ethinyl estradiol,,,
drugInteractions,32b48ea0-a215-43b8-83b4-a5435a686d68,8/1/2011,8,NET,norethindrone,,,
drugInteractions,32b48ea0-a215-43b8-83b4-a5435a686d68,8/1/2011,8,EE,ethinyl estradiol,,,
drugInteractions,b00b296d-6c34-48c8-9cfb-71ccc5c9a908,6/10/2011,1,MAOI,monoamine oxidase inhibitors,,,
drugInteractions,6faf465b-c3a3-4ae7-9e16-1ba758f6962a,4/26/2012,3,THC,tetrahydrocannabinol,,,
drugInteractions,bb06af33-8ff7-0b02-0029-d628f62e1382,1/31/2008,1,MAOI,monoamine oxidase inhibitor,,,
drugInteractions,3942d30d-827b-46c7-8454-3020d5d7865d,7/9/2010,1,ODV,O-desmethylvenlafaxine,,,
drugInteractions,85d3ce8b-8966-45d9-bdaf-f6f0475096e1,11/23/2011,3,ODV,O-desmethylvenlafaxine,,,
drugInteractions,eda64039-771b-41d7-b9c4-970cfbf5fbb9,1/3/2012,2,THC,tetrahydrocannabinol,,,
drugInteractions,b3230c81-2a58-4033-848b-194dd2439843,12/21/2010,162,MAOI,monoamine oxidase inhibitor,,,
drugInteractions,6a9cbc29-9f15-4b24-8d86-206b82887f3d,3/30/2012,8,ENF,enfuvirtide,,,
drugInteractions,c4de72a8-2a75-4984-ce90-e4870226dc12,6/21/2012,10,MAOI,monoamine oxidase inhibitors,,,
drugInteractions,56ad5b97-8e5f-48a5-b2ba-a5484b43d018,1/1/2012,3,THC,tetrahydrocannabinol,,,
drugInteractions,cf73c2e3-f43b-403f-a461-47438a7270ad,6/10/2011,4,MAOI,monoamine oxidase inhibitors,,,
drugInteractions,3ccada47-7eb9-285d-5059-06afb4466114,1/31/2008,1,MAOI,monoamine oxidase inhibitor,,,
drugInteractions,F9EB07A2-5EBC-40EA-9890-1A0B03E859FF,3/30/2007,1,t-PA,tissue-type plasminogen activator,,,
drugInteractions,92919b7e-b499-4afb-8f78-1b1fff099bae,12/14/2011,5,LNG,levonorgestrel,,,
drugInteractions,42abbb51-a476-4837-bdf9-01eb288ceec2,7/13/2011,4,LNG,levonorgestrel,,,
drugInteractions,2E0570E7-D28F-4936-CBA8-81EE0C4C3547,9/11/2006,1,MAOI,monoamine oxidase inhibitors,,,
drugInteractions,55889b3d-74c9-4638-9a14-6a4ca3a99f7f,3/2/2009,1,ODV,O-desmethylvenlafaxine,,,
drugInteractions,3451ced4-f2a3-476e-a279-b96c8c3f0acf,12/15/2010,145,HO-NEF,hydroxynefazodone,,,
drugInteractions,e07fa54e-f4ee-496d-a7e9-533c85564be1,1/17/2011,1,MAOI,monoamine oxidase inhibitor,,,
drugInteractions,7027be98-61d6-a986-c9df-60ceef5f7ff0,10/29/2010,5,ODV,O-desmethylvenlafaxine,,,
drugInteractions,989705dd-929b-4b62-9ef4-e768f0e366cb,8/19/2010,1,ODV,O-desmethylvenlafaxine,,,
drugInteractions,ad14d292-6b01-4d5c-bb90-a5dde44ccb1c,12/15/2010,147,HO-NEF,hydroxynefazodone,,,
drugInteractions,4d78fba4-51af-472c-8b64-5505cb4b91dc,7/8/2011,1,NET,norethindrone,,,
drugInteractions,4d78fba4-51af-472c-8b64-5505cb4b91dc,7/8/2011,1,EE,ethinyl estradiol,,,
drugInteractions,1c713b59-a628-42e6-b166-ae71c3913284,4/30/2011,4,LNG,levonorgestrel,,,
drugInteractions,e057c25f-dfb3-419b-930b-7f272af400e5,11/23/2010,102,ODV,O-desmethylvenlafaxine,,,
drugInteractions,35312f49-decf-428d-bf5f-4215b762ed3c,6/10/2011,7,NET,norethindrone,,,
drugInteractions,35312f49-decf-428d-bf5f-4215b762ed3c,6/10/2011,7,EE,ethinyl estradiol,,,
drugInteractions,234076ca-0dca-4670-aa6a-6f7c1f74ff3a,9/13/2011,1,NET,norethindrone,,,
drugInteractions,234076ca-0dca-4670-aa6a-6f7c1f74ff3a,9/13/2011,1,EE,ethinyl estradiol,,,
drugInteractions,b23637e5-d37f-41b5-ba76-fc053e903bc2,5/6/2011,6,ODV,O-desmethylvenlafaxine,,,
drugInteractions,682a1210-b26e-426e-8ffe-d25d91bdd608,2/1/2012,8,LNG,levonorgestrel,,,
drugInteractions,4f43644d-9b04-6911-9be5-81b6e25557cc,3/14/2011,4,LNG,levonorgestrel,,,
drugInteractions,e4a1887d-c0a8-4d18-9233-0d9c9d366807,12/7/2010,127,HO-NEF,hydroxynefazodone,,,
drugInteractions,8FBA17DA-573A-425B-B1D7-7DDEEEF3C957,6/3/2008,1,ODV,O-desmethylvenlafaxine,,,
drugInteractions,0e817af0-85f5-46a5-82a4-e08b1f701e86,5/24/2011,3024,MAOI,monoamine oxidase inhibitor,,,
drugInteractions,a9b0d279-118b-4372-bd51-d4bad9c1cfca,12/15/2010,1,THC,tetrahydrocannabinol,,,
drugInteractions,340d2619-4b29-456b-a3ac-0fa329e0b304,9/7/2011,1,NET,norethindrone,,,
drugInteractions,340d2619-4b29-456b-a3ac-0fa329e0b304,9/7/2011,1,EE,ethinyl estradiol,,,
drugInteractions,9e1353d7-83d1-4522-9352-5545db044a50,1/17/2011,1,MAOI,monoamine oxidase inhibitor,,,
drugInteractions,1b5a2dc7-0570-4977-876d-88b4176844a1,8/6/2010,2,ENF,enfuvirtide,,,
drugInteractions,45454555-7402-41cb-a452-e6a76e04f387,3/14/2012,11,MAOI,monoamine oxidase inhibitor,,,
drugInteractions,38b8c4a5-710f-453c-b7c1-38f19e38e808,8/22/2011,1,NET,norethindrone,,,
drugInteractions,38b8c4a5-710f-453c-b7c1-38f19e38e808,8/22/2011,1,EE,ethinyl estradiol,,,
drugInteractions,9f84ea84-2d8b-4d91-a33f-7dfb5df937dc,7/24/2012,9,MPA,mycophenolic acid,,,
drugInteractions,2c4cd6a8-b95a-4632-bbb8-c633a8561d43,3/14/2012,2,ODV,O-desmethylvenlafaxine,,,
drugInteractions,47fd4c44-56fa-4864-af5d-7b65c7b746d7,2/15/2011,1,NET,norethindrone,,,
drugInteractions,47fd4c44-56fa-4864-af5d-7b65c7b746d7,2/15/2011,1,EE,ethinyl estradiol,,,
drugInteractions,62c47df4-2c71-437e-b142-bc193f6277f0,3/20/2012,4,MAOI,monoamine oxidase inhibitor,,,
drugInteractions,1f0fa7d6-9309-4cf6-b842-3924ec8aebe7,12/6/2011,3320,ODV,O-desmethylvenlafaxine,,,
drugInteractions,1f5f940c-d5b9-4d09-958d-246931e167af,11/7/2011,5,NET,norethindrone,,,
drugInteractions,1f5f940c-d5b9-4d09-958d-246931e167af,11/7/2011,5,EE,ethinyl estradiol,,,
drugInteractions,4a2ef860-4349-f2a0-0815-6d47ba08e311,3/27/2009,2,NET,norethindrone,,,
drugInteractions,4a2ef860-4349-f2a0-0815-6d47ba08e311,3/27/2009,2,EE,ethinyl estradiol,,,
drugInteractions,239dcefe-45a9-48f5-a6f1-1ac6546e0da2,4/18/2007,1,HO-NEF,hydroxynefazodone,,,
drugInteractions,6bc0214b-b6f9-463d-a689-a93e59512b60,1/18/2010,2,MAOI,monoamine oxidase inhibitor,,,
drugInteractions,73667241-b95a-49b0-9c51-a4289f20d5c2,7/28/2010,1,ENF,enfuvirtide,,,
drugInteractions,b9e7c593-9499-49c7-8775-1e7761176857,11/20/2010,96,LNG,levonorgestrel,,,
drugInteractions,424c69ef-b5a4-4480-98f1-6c8bed9cbcf2,12/15/2010,147,HO-NEF,hydroxynefazodone,,,
drugInteractions,aa756b80-11eb-4f67-abb8-8babcee728b2,7/8/2010,4,MPA,mycophenolic acid,,,
drugInteractions,9de97bb7-36e8-4126-bede-d48375da15df,12/21/2010,6,ODV,O-desmethylvenlafaxine,,,
drugInteractions,47c21109-6e7e-4647-9963-d2151f5ef820,10/13/2011,1,HO-NEF,hydroxynefazodone,,,
drugInteractions,8887de7e-eba5-4f00-97ca-5077cfaa361b,7/19/2012,5,NET,norethindrone,,,
drugInteractions,8887de7e-eba5-4f00-97ca-5077cfaa361b,7/19/2012,5,EE,ethinyl estradiol,,,
drugInteractions,9832312e-0310-4ab6-8501-afa976fc7eb2,2/29/2012,4,MAOs,Monoamine oxidase inhibitors,,,
supply,a5ddc0dc-c176-4705-a9a0-e4ecaf1f5667,3/6/2012,16,MAOI,monoamine oxidase inhibitor,,,
supply,C7C7FEF7-AD39-420B-8766-69514C23A243,5/11/2006,1,HDPE,high density polyethylene,,,
supply,A000ABB9-92A1-4C84-8932-CD40C476DC00,12/7/2006,1,CFCs,chlorofluorocarbons,,,
supply,c89eb8fd-6c31-4f8b-8103-1f559424eda1,10/9/2006,1,CFCs,chlorofluorocarbons,,,
supply,9448e8ba-b73a-4d2a-b58c-afdcd19f8e12,8/4/2010,18,PEG,polyethylene glycol,,,
supply,BB56DF52-5ABF-47DC-AB8D-902CFE19CCB2,2/25/2008,1,ALFENTA,alfentanil hydrochloride,,,
supply,14710a71-e2e9-4e4e-bd65-1c296f70c166,12/8/2009,5,HDPE,high-density polyethylene,,,
supply,DE3C370C-7247-4260-8C6B-C0C35EB6F9BA,10/12/2007,2,Codeine,codeine phosphate,,,
supply,58860ee1-5a9d-4422-b9bc-78e8b7958b53,3/2/2010,1,CFCs,chlorofluorocarbons,,,
supply,9b8ea543-1de8-472f-9666-34f99ca2f183,2/27/2006,1,AMPHOTEC,Amphotericin B,,,
supply,bae7d458-01ce-423a-acae-40a834057103,6/1/2012,2,thiamine,Thiamine Mononitrate,,,
supply,bae7d458-01ce-423a-acae-40a834057103,6/1/2012,2,folic acid,Folic Acid,,,
supply,bae7d458-01ce-423a-acae-40a834057103,6/1/2012,2,pyridoxine,Pyridoxine Hydrochloride,,,
supply,bae7d458-01ce-423a-acae-40a834057103,6/1/2012,2,riboflavin,Riboflavin,,,
supply,77104557-087c-4bc5-9bea-521843b83e07,12/31/2006,1,CFC's,chlorofluorocarbons,,,
supply,a22565c1-fe03-4cd4-bb9c-f65b5fe3c194,3/14/2011,2,LDPE,low density polyethylene,,,
supply,808E2B04-9E84-440A-B00E-2CBE858041DA,11/27/2007,1,CFC's,chlorofluorocarbons,,,
supply,9720518e-9f70-4811-84ca-69a526d8a904,1/9/2012,1,MAOI,monoamine oxidase inhibitor,,,
supply,e35aa027-aef2-485d-927c-ab350f51f977,2/16/2006,1,MEXITIL,mexiletine hydrochloride,,,
supply,545776FE-63DF-44AB-ACE3-F3D73D2E0092,5/11/2006,1,FLUOR-OP,fluorometholone ophthalmic suspension,,,
supply,5F06A992-93AE-461D-B605-9962249DAEBA,12/7/2006,1,CFCs,chlorofluorocarbons,,,
supply,f35e3310-0246-446a-aabe-c17f9000ce26,10/6/2006,1,CFCs,chlorofluorocarbons,,,
supply,4021a77c-36ad-4f3a-bb4b-b44de96173b2,12/8/2009,1,HDPE,high-density polyethylene,,,
supply,5e2dbda9-aceb-4bfb-9c3f-e7b6118f580c,10/27/2009,1,OND,ondansetron,,,
supply,244DA533-0B72-4015-37B0-A16744490B28,6/12/2008,2,CFCs,chlorofluorocarbons,,,
supply,Lf69f100f-c766-490f-9143-5e8e0c8cb7c9,9/14/2007,1,LDPE,low density polyethylene,,,
supply,DA9B26BB-D2D7-4113-A0F9-C6C2280F4875,2/6/2006,1,TROVAN,trovafloxacin mesylate,,,
supply,07315965-0be6-4c18-a8b9-25821a3732e2,10/26/2006,1,CFC's,chlorofluorocarbons,,,
supply,0e996cf8-6975-452a-a84c-ca1033a629b1,5/28/2007,1,CFCs,chlorofluorocarbons,,,
supply,EC09AB1C-52FA-4F41-BF65-A632DCE8F097,3/31/2007,1,Ismo,isosorbide mononitrate,,,
supply,5f411d45-7836-43b2-bf0e-a524b0b626f1,4/15/2009,2,LDPE,low density polyethylene,,,
supply,93d73c30-f90d-435b-a31b-036884caa7b4,10/12/2007,1,PEG,polyethylene glycol,,,
supply,5B555346-57CD-44BB-8A60-BF7124B62C30,5/11/2006,1,HDPE,high density polyethylene,,,
supply,7179a2e5-f2e5-4b68-9ea6-92d0f680f1a7,5/14/2010,2,LDPE,low density polyethylene,,,
supply,b4219281-d79f-45ac-86dd-82c399415032,1/9/2012,1,MAOI,monoamine oxidase inhibitor,,,
supply,394d3238-f763-4f67-bb9d-08751ec6ed31,1/4/2006,1,CFC's,chlorofluorocarbons,,,
supply,fbe6d514-9d89-48f7-80a0-d1b41983f203,3/10/2006,1,CFC's,chlorofluorocarbons,,,
supply,a4d91839-eefa-44dc-8162-eb4f8bd426a2,3/6/2012,6,MAOI,monoamine oxidase inhibitor,,,
supply,cf6676ff-1122-4495-b64d-f70771a09633,1/22/2010,1,HDPE,high-density polyethylene,,,
indication,b1a6939e-8d77-449d-b55f-0fd9a500352a,10/15/2010,1,MINOCIN,minocycline hydrochloride,,,
indication,f11b1d88-74ca-4a6d-89fb-40d0f51bca95,10/12/2007,1,GH,growth hormone,,,
indication,3636a53b-caaf-4af9-8105-9a27ec7473c4,8/16/2010,1,MINOCIN,minocycline,,,
indication,614401aa-cda6-4cea-88e8-11967fbdde6b,8/11/2010,2,MINOCIN,minocycline hydrochloride,,,
indication,d76a0419-05ee-437e-884c-65807aea9569,2/22/2012,11,HCTZ,hydrochlorothiazide,,,
indication,DE3C370C-7247-4260-8C6B-C0C35EB6F9BA,10/12/2007,2,Codeine,codeine phosphate,,,
indication,abfeded8-9da9-4884-8429-bed89763d873,2/22/2012,11,HCTZ,hydrochlorothiazide,,,
overdosage,d94dc983-98a9-47e1-9336-95c9142ca497,11/29/2011,3268,NAC,N-acetylcysteine,,,
overdosage,d7f92280-7a55-4a12-a42b-2ea21a29230c,12/6/2011,3323,NAC,N-acetylcysteine,,,
overdosage,783be2dd-5648-4549-8ebf-5067f1b1e5f1,2/2/2012,3522,NAC,N-acetylcysteine,,,
overdosage,60f43308-1deb-4f05-8f17-aa49ebdcf498,8/5/2011,1,NAC,N-acetylcysteine,,,
overdosage,7d2d79e4-33ae-4436-98e3-14e91753886c,8/6/2009,1003,NAC,N-acetylcysteine,,,
overdosage,04c8ab3f-b026-4009-bf0f-d6eb71517d23,4/1/2010,1,NAC,N-acetylcysteine,,,
overdosage,35b99e65-32d3-43bc-89d9-2e7c7838aa14,4/20/2011,1,NAC,N-acetylcysteine,,,
overdosage,469779cc-9a1b-470b-b54e-cf30191b97a4,11/10/2011,1,NAC,N-acetylcysteine,,,
overdosage,6f8cced0-4749-4a11-8f00-96d8c23c1cfd,7/11/2011,6,NAC,N-acetylcysteine,,,
overdosage,77e4446e-78a0-4596-9679-15938eb0f892,7/24/2012,1,NAC,N-acetylcysteine,,,
overdosage,2cb9090d-76dd-44a2-9590-37c6e7ed495b,11/10/2009,4,NAC,N-acetylcysteine,,,
overdosage,eda68f78-442e-4062-a799-600fafbd389b,7/2/2012,3895,NAC,N-acetylcysteine,,,
overdosage,a3185171-0581-4e49-9be0-ec2dce877aa4,6/5/2009,1003,NAC,N-acetylcysteine,,,
overdosage,fbed0f64-1143-4439-8f03-88f393d20390,5/10/2011,1,NAC,N-acetylcysteine,,,
overdosage,53b3ed76-db40-4aa8-8c55-21991d557b42,4/29/2012,3,NAC,N-acetylcysteine,,,
overdosage,0525e04f-91b7-4d75-8ff9-a6fb5705d993,2/6/2012,1,EDTA,ethylenediaminetetraacetic acid,,,
overdosage,944d3e60-7eee-11de-a413-0002a5d5c51b,11/22/2011,9,NAC,N-acetylcysteine,,,
overdosage,c8be6c8d-7c55-459b-bc16-7651c2fd6e27,1/31/2012,5,NAC,N-acetylcysteine,,,
overdosage,63841f53-a567-4102-80b5-3565d9b52373,7/1/2011,2,NAC,N-acetylcysteine,,,
overdosage,d4f97887-3353-441e-b1e3-c32bde2a9016,4/26/2012,1,NAC,N-acetylcysteine,,,
overdosage,73c1059b-0c7d-42ef-9827-f018858fc447,7/6/2011,12,NAC,N-acetylcysteine,,,
overdosage,69760d70-a6d5-4a00-9437-dce466e103a2,11/9/2011,3112,NAC,N-acetylcysteine,,,
overdosage,453f8966-f89c-4ab2-b91e-c7bb50304028,3/22/2012,1,NAC,N-acetylcysteine,,,
overdosage,61c36d81-8f1a-446d-8db5-72c3635589fc,4/3/2012,3725,NAC,N-acetylcysteine,,,
overdosage,4dd36cf5-8f73-404a-8b1d-3bd53bd90c25,2/13/2012,17,NAC,N-acetylcysteine,,,
overdosage,0e4ff499-980a-4c3d-b921-abcea52654fe,2/7/2012,3,NAC,N-acetylcysteine,,,
precautions,0bbc6889-0fd5-4763-97f4-061f5a50c7b1,4/15/2009,1,ACTH,adrenocorticotropic hormone,,,
precautions,b00b296d-6c34-48c8-9cfb-71ccc5c9a908,6/10/2011,1,MAOI,monoamine oxidase inhibitors,,,
precautions,3942d30d-827b-46c7-8454-3020d5d7865d,7/9/2010,1,ODV,O-desmethylvenlafaxine,,,
precautions,40c158ae-07b0-fae9-eecc-5acf8273c526,3/27/2009,1,NET,norethindrone,,,
precautions,40c158ae-07b0-fae9-eecc-5acf8273c526,3/27/2009,1,EE,ethinyl estradiol,,,
precautions,d5a26c5e-9c3e-4781-8c08-62b91d21a68d,11/7/2006,1,LH,luteinizing hormone,,,
precautions,d5a26c5e-9c3e-4781-8c08-62b91d21a68d,11/7/2006,1,FSH,follicle stimulating hormone,,,
precautions,eb28f976-ce74-47e1-7757-c0832c28be75,6/14/2012,10,ODV,O-desmethylvenlafaxine,,,
precautions,e883e5ac-4ee4-466e-bb6c-bff0a5ea8479,9/1/2011,2,NET,norethindrone,,,
precautions,e883e5ac-4ee4-466e-bb6c-bff0a5ea8479,9/1/2011,2,EE,ethinyl estradiol,,,
precautions,42abbb51-a476-4837-bdf9-01eb288ceec2,7/13/2011,4,LNG,levonorgestrel,,,
precautions,55889b3d-74c9-4638-9a14-6a4ca3a99f7f,3/2/2009,1,ODV,O-desmethylvenlafaxine,,,
precautions,17471bd6-4f48-40e0-952e-6a69bd0eeec9,9/1/2011,2,NET,norethindrone,,,
precautions,17471bd6-4f48-40e0-952e-6a69bd0eeec9,9/1/2011,2,EE,ethinyl estradiol,,,
precautions,4a50cc68-af58-44e7-a278-728e781f0d4e,5/13/2011,1,ACTH,adrenocorticotropic hormone,,,
precautions,7027be98-61d6-a986-c9df-60ceef5f7ff0,10/29/2010,5,ODV,O-desmethylvenlafaxine,,,
precautions,56145d1a-1c0c-4c39-951e-45b9f324abcb,12/1/2010,1,NET,norethindrone,,,
precautions,56145d1a-1c0c-4c39-951e-45b9f324abcb,12/1/2010,1,EE,ethinyl estradiol,,,
precautions,d3e5fbbf-4a1f-4aa2-8e80-9729f6cf04ee,4/14/2008,1,UFH,unfractionated heparin,,,
precautions,04c95282-2e10-4ab5-baf2-62d44dd8f22f,11/30/2011,4,ODV,O-desmethylvenlafaxine,,,
precautions,45af3eda-caaa-4478-9372-95aa65adc9b3,5/29/2009,2,MPA,mycophenolic acid,,,
precautions,cf2d9bee-f8e3-477a-e4b4-f0e82657b7d2,1/22/2010,11,ODV,O-desmethylvenlafaxine,,,
precautions,72efad5f-0909-46a5-aa13-ac24fe015fe6,5/4/2011,3,ODV,O-desmethylvenlafaxine,,,
precautions,88ac83d9-798a-4610-b242-c443b43bdc88,8/3/2010,2,MPA,mycophenolic acid,,,
precautions,d87fba09-06b6-41a8-867c-a8428fce240e,5/13/2011,4,ODV,O-desmethylvenlafaxine,,,
precautions,7f9eb38f-0dfa-4798-b3c1-32381d33affa,12/5/2011,6,NET,norethindrone,,,
precautions,7f9eb38f-0dfa-4798-b3c1-32381d33affa,12/5/2011,6,EE,ethinyl estradiol,,,
precautions,106d0d7b-925b-74e7-83cb-562144ce1f92,11/27/2009,3,ODV,O-desmethylvenlafaxine,,,
precautions,04b9b820-228c-d7f8-519d-d65feb897199,5/7/2012,2,ODV,O-desmethylvenlafaxine,,,
precautions,84034bf7-0ba3-060d-73f5-275de6aff417,6/28/2010,1,ODV,O-desmethylvenlafaxine,,,
precautions,c8b93fc1-472c-4890-8d02-2ee4f7175c22,10/25/2007,1,VMA,vanillylmandelic acid,,,
precautions,8944EA18-016E-4971-876D-2365FAC190EA,4/21/2008,1,MAOI's,monoamine oxidase inhibitors,,,
precautions,83cb4d74-d75e-4aad-9bae-a09a5a789806,6/20/2011,1,ODV,O-desmethylvenlafaxine,,,
precautions,01735685-40e0-4323-af5a-91db399f6451,4/2/2012,3,VMA,vanillylmandelic acid,,,
precautions,51334651-7a7f-4653-bf9d-d5be04fd902d,5/4/2011,1,ODV,O-desmethylvenlafaxine,,,
precautions,9a30e1b5-272b-4109-ad6c-a3c9a895822f,7/9/2012,5,ODV,O-desmethylvenlafaxine,,,
precautions,7f3d81cc-caec-47a0-b703-fdff6fbc3f6f,4/3/2009,1,NET,norethindrone,,,
precautions,7f3d81cc-caec-47a0-b703-fdff6fbc3f6f,4/3/2009,1,EE,ethinyl estradiol,,,
precautions,dede8847-972b-41df-9f68-2e069f269af8,4/18/2008,6,NET,norethindrone,,,
precautions,dede8847-972b-41df-9f68-2e069f269af8,4/18/2008,6,EE,ethinyl estradiol,,,
precautions,99991CC3-7271-44FC-91C3-3CAB0BBE7645,9/12/2006,1,DEA,desethylamiodarone,,,
precautions,e608d164-5f77-40f5-a72b-26dd20ad7a8a,5/21/2010,1,NET,norethindrone,,,
precautions,e608d164-5f77-40f5-a72b-26dd20ad7a8a,5/21/2010,1,EE,ethinyl estradiol,,,
precautions,b23637e5-d37f-41b5-ba76-fc053e903bc2,5/6/2011,6,ODV,O-desmethylvenlafaxine,,,
precautions,68d04ab4-19c6-4d74-b346-2fe96452b4ad,1/29/2007,1,TFMA,4-trifluoromethylaniline,,,
precautions,E542EE34-6519-4934-ABBD-58FD8A7440AF,2/12/2008,3,DEA,desethylamiodarone,,,
precautions,6cef2a80-c7e5-44a2-92db-06082092bb35,12/10/2010,1,MPA,mycophenolic acid,,,
precautions,09f988b2-e313-4568-964e-fe1f23ab2b59,8/31/2010,1,MAOI,monoamine oxidase inhibitors,,,
precautions,5f742224-618e-4f4c-bdec-7693be99c697,5/29/2009,1,MPA,mycophenolic acid,,,
precautions,53c3e7ac-1852-4d70-d2b6-4fca819acf26,11/29/2011,14,ODV,O-desmethylvenlafaxine,,,
precautions,c7156e83-f344-4e9f-a42d-6dc8ce90a0b9,3/31/2011,1,METROGEL,metronidazole topical gel,,,
precautions,DE3C370C-7247-4260-8C6B-C0C35EB6F9BA,10/12/2007,2,Codeine,codeine phosphate,,,
precautions,db64c361-7960-4e86-8c71-5d96a381ae23,8/10/2011,3,ODV,O-desmethylvenlafaxine,,,
precautions,f15b043d-fcfa-4ade-a3da-76700c0c5c2a,12/28/2010,1,MPA,mycophenolic acid,,,
precautions,92123CFA-5BD5-4554-8D5D-B877D5CB9C02,6/19/2007,1,VMA,vanillylmandelic acid,,,
precautions,1700a5b8-4029-424a-bfed-15f6737dd210,12/1/2009,1,LDPE,low-density polyethylene,,,
precautions,AA249ECD-AFD3-4800-B196-D4F7B8C8FC6E,9/4/2007,1,DHA,dapsone hydroxylamine,,,
precautions,4a2ef860-4349-f2a0-0815-6d47ba08e311,3/27/2009,2,NET,norethindrone,,,
precautions,4a2ef860-4349-f2a0-0815-6d47ba08e311,3/27/2009,2,EE,ethinyl estradiol,,,
precautions,5c44de38-a291-471d-8335-abc65e04387d,5/19/2011,4,NET,norethindrone,,,
precautions,5c44de38-a291-471d-8335-abc65e04387d,5/19/2011,4,EE,ethinyl estradiol,,,
precautions,652215b5-f950-4bc9-9de4-d66a5b70019b,12/22/2009,2,HCTZ,hydrochlorothiazide,,,
precautions,652215b5-f950-4bc9-9de4-d66a5b70019b,12/22/2009,2,TA,triamterene,,,
precautions,A9630311-A5DB-4FBA-B95E-5E13AD286BC8,11/27/2006,2,ACTH,adrenocorticotropic hormone,,,
precautions,239dcefe-45a9-48f5-a6f1-1ac6546e0da2,4/18/2007,1,HO-NEF,hydroxynefazodone,,,
precautions,6be70efb-322e-4e65-9851-a7d167065dd8,12/3/2010,2,ODV,O-desmethylvenlafaxine,,,
precautions,93983865-362f-40a8-ba41-a8bcb99e35cb,4/26/2011,1,MPA,mycophenolic acid,,,
precautions,5351fe67-17d9-42ec-9e8b-6585fdb9e29e,4/12/2011,1,ODV,O-desmethylvenlafaxine,,,
precautions,d02af310-d097-4886-86e5-adcf6bca0533,9/26/2007,1,ALA,aminolevulinate,,,
precautions,8a2302ca-5c25-4d2d-9ffe-320080934aab,9/24/2010,1,ODV,O-desmethylvenlafaxine,,,
precautions,23b73332-cbb3-4155-8ad8-b24619cdea85,4/4/2012,1,MPA,mycophenolic acid,,,
precautions,1be1be3a-304b-4e31-8732-335247029191,4/18/2011,1,ODV,O-desmethylvenlafaxine,,,
precautions,5666ece8-9a10-4dcc-a7dc-3cd29df10e28,8/24/2011,1,VMA,vanillylmandelic acid,,,
precautions,011eedbd-efb1-4d4e-99f0-b6bca81fb5ad,5/25/2012,3,NET,norethindrone,,,
precautions,011eedbd-efb1-4d4e-99f0-b6bca81fb5ad,5/25/2012,3,EE,ethinyl estradiol,,,
precautions,a703595c-1215-453e-b63e-9f0cdcdd1eaa,11/29/2011,3266,NET,norethindrone,,,
precautions,a703595c-1215-453e-b63e-9f0cdcdd1eaa,11/29/2011,3266,EE,ethinyl estradiol,,,
precautions,1af94c80-2b17-409a-98f6-ce00f942351d,7/20/2012,5,NET,norethindrone,,,
precautions,1af94c80-2b17-409a-98f6-ce00f942351d,7/20/2012,5,EE,ethinyl estradiol,,,
precautions,c32ccd4d-77b4-4451-8c03-ffc6484bc1f3,4/15/2011,1,ODV,O-desmethylvenlafaxine,,,
precautions,6d46258b-31d0-4e43-9acd-4c821f09ec0f,1/28/2010,1,NET,norethindrone,,,
precautions,6d46258b-31d0-4e43-9acd-4c821f09ec0f,1/28/2010,1,EE,ethinyl estradiol,,,
precautions,1C3A94FF-91F0-4BC1-8BC8-1B6AA87E8026,4/5/2007,1,ALA,delta-aminolevulinic acid,,,
precautions,B1E6C7AB-EEFE-4089-B403-EDEAAB4F6E36,1/3/2007,1,VMA,vanillylmandelic acid,,,
precautions,8fefc750-b4a6-42a5-ae69-368b25c76365,12/5/2011,3312,NET,norethindrone,,,
precautions,8fefc750-b4a6-42a5-ae69-368b25c76365,12/5/2011,3312,EE,ethinyl estradiol,,,
precautions,2d9513e0-2fb8-46c9-bbd6-b03efd31c3ef,11/1/2009,1,NET,norethindrone,,,
precautions,2d9513e0-2fb8-46c9-bbd6-b03efd31c3ef,11/1/2009,1,EE,ethinyl estradiol,,,
precautions,85d3ce8b-8966-45d9-bdaf-f6f0475096e1,11/23/2011,3,ODV,O-desmethylvenlafaxine,,,
precautions,7efb04ae-3d39-4853-9741-466c8973e8b2,8/30/2011,1,ACTH,adrenocorticotropic hormone,,,
precautions,a821ed7b-53cf-438d-b8ab-6d7ac1c08912,11/18/2011,3219,ODV,O-desmethylvenlafaxine,,,
precautions,a4e1d3bc-4e97-4ff0-9e30-22a699c96072,12/13/2011,1,ODV,O-desmethylvenlafaxine,,,
precautions,cf73c2e3-f43b-403f-a461-47438a7270ad,6/10/2011,4,MAOI,monoamine oxidase inhibitors,,,
precautions,01C3122F-E791-40A5-B52E-963CB6685F71,3/9/2007,2,DEA,desethylamiodarone,,,
precautions,28f12fa3-b5ef-41c7-a750-32c80d8881cf,8/29/2011,1,ODV,O-desmethylvenlafaxine,,,
precautions,2E0570E7-D28F-4936-CBA8-81EE0C4C3547,9/11/2006,1,MAOI,monoamine oxidase inhibitors,,,
precautions,b6d3c9af-53f7-4c14-8608-f41a3ef9894d,4/26/2011,3,MAOI,monoamine oxidase inhibitors,,,
precautions,35f4790c-1235-49fe-bb9b-842f9e8c09f7,11/16/2011,3196,ODV,O-desmethylvenlafaxine,,,
precautions,7bc5effe-c9ed-4f20-896b-83c5bfb2c621,2/1/2011,6,ACTH,adrenocorticotropic hormone,,,
precautions,e0990ade-320e-4259-8c0e-6d5ef23bc673,4/15/2011,1,ODV,O-desmethylvenlafaxine,,,
precautions,53b73f2a-d839-41b5-bc9c-aeb3e9dba304,3/4/2012,9,ODV,O-desmethylvenlafaxine,,,
precautions,49bef388-71ff-43b1-87a8-9fd506a0e63e,9/3/2009,2,ODV,O-desmethylvenlafaxine,,,
precautions,2bb09fc1-1c0a-4586-9af9-5aed8d4322db,9/13/2011,2,ODV,O-desmethylvenlafaxine,,,
precautions,09feeadb-d4e6-47dd-8d1e-b03052a9cc5d,11/27/2009,3,ODV,O-desmethylvenlafaxine,,,
precautions,941E1EC2-1F14-4153-A5EA-CF7669D5EFD1,1/15/2008,1,VMA,vanillylmandelic acid,,,
precautions,b4048138-3b43-4952-9c4d-f9278792f2b5,8/9/2011,1,ODV,O-desmethylvenlafaxine,,,
precautions,1b628a38-3557-4fa4-9e08-4c7de40f9d82,8/9/2010,1,MAOI,monoamine oxidase inhibitors,,,
precautions,341720f7-f76f-498b-856f-3d207ad63feb,1/30/2011,1,ODV,O-desmethylvenlafaxine,,,
precautions,682a1210-b26e-426e-8ffe-d25d91bdd608,2/1/2012,8,LNG,levonorgestrel,,,
precautions,b2cb63c9-f825-4991-9a2c-6260f1bbcc2c,5/23/2012,4,FSH,follicle-stimulating hormone,,,
precautions,b2cb63c9-f825-4991-9a2c-6260f1bbcc2c,5/23/2012,4,LH,luteinizing hormone,,,
precautions,abfc6b75-1ed5-41f1-0484-4597488237bc,2/17/2012,10,VMA,vanillylmandelic acid,,,
precautions,787cda7d-7aa4-4909-8e5c-f2fcf68828e4,6/29/2010,1,VMA,vanillylmandelic acid,,,
precautions,abd87058-923f-4767-986c-278201c0e688,10/5/2011,1,FSH,follicle-stimulating hormone,,,
precautions,abd87058-923f-4767-986c-278201c0e688,10/5/2011,1,LH,luteinizing hormone,,,
precautions,2e8f0889-57ca-498a-8e91-b8a24bbe47fd,5/31/2011,1,ODV,O-desmethylvenlafaxine,,,
precautions,185d90ab-1ba4-dd59-0565-e35f0fd39a2d,6/13/2008,1,ODV,O-desmethylvenlafaxine,,,
precautions,4C52C904-8137-4B10-8A85-D9B96C2D8A00,5/10/2006,1,oxine,oxyquinoline,,,
precautions,46ac55cf-d85e-4c34-bb33-f49e078c4a03,3/14/2012,5,MPA,mycophenolic acid,,,
precautions,a5e32167-9ee0-4fbb-8577-c67fbc794d78,5/31/2012,9,ODV,O-desmethylvenlafaxine,,,
precautions,50bc013e-b5df-40e0-95e5-2527a62dcda0,2/9/2012,3,NET,norethindrone,,,
precautions,50bc013e-b5df-40e0-95e5-2527a62dcda0,2/9/2012,3,EE,ethinyl estradiol,,,
precautions,9f84ea84-2d8b-4d91-a33f-7dfb5df937dc,7/24/2012,9,MMF,mycophenolate mofetil,,,
precautions,9f84ea84-2d8b-4d91-a33f-7dfb5df937dc,7/24/2012,9,MPA,mycophenolic acid,,,
precautions,47fd4c44-56fa-4864-af5d-7b65c7b746d7,2/15/2011,1,NET,norethindrone,,,
precautions,47fd4c44-56fa-4864-af5d-7b65c7b746d7,2/15/2011,1,EE,ethinyl estradiol,,,
precautions,9b5885cc-ef96-4081-8975-9febc6772dc0,2/13/2012,5,ODV,O-desmethylvenlafaxine,,,
precautions,e5a31f69-c237-49b7-83a2-d04eebbc30ce,7/21/2012,9,ODV,O-desmethylvenlafaxine,,,
precautions,2a84b9b5-cb10-46b7-b5a3-2cd9b4ffb0f3,11/29/2011,14,ODV,O-desmethylvenlafaxine,,,
precautions,4fabbef0-1838-4f70-aaf9-9550bd5f6204,10/11/2011,2,ODV,O-desmethylvenlafaxine,,,
precautions,ad98682f-e421-4cf3-85f5-a042a3708262,3/17/2006,1,VMA,vanillylmandelic acid,,,
precautions,2c3f8268-ef43-d58c-7da6-dd44f8feb3be,7/13/2010,2,ODV,O-desmethylvenlafaxine,,,
precautions,af3eb64f-edfb-470f-924b-ef592b5b88dc,9/1/2011,3,NET,norethindrone,,,
precautions,af3eb64f-edfb-470f-924b-ef592b5b88dc,9/1/2011,3,EE,ethinyl estradiol,,,
precautions,f35ec9aa-2be6-40c9-9112-b9e3b80f8fa8,10/26/2009,5,HO-NEF,hydroxynefazodone,,,
precautions,8d06eb3d-16bd-495a-b58f-90877f3d5188,3/11/2011,1,ODV,O-desmethylvenlafaxine,,,
precautions,4c401522-0108-49cb-8a41-fb5ad4dd0fb1,8/24/2011,10,ODV,O-desmethylvenlafaxine,,,
precautions,b379b413-5d66-4adb-8521-3978f10bbd1d,12/19/2011,4,ODV,O-desmethylvenlafaxine,,,
precautions,adfb8f6b-a7bb-4ac2-b2aa-fec6d56630ad,3/24/2011,2,FSH,follicle-stimulating hormone,,,
precautions,adfb8f6b-a7bb-4ac2-b2aa-fec6d56630ad,3/24/2011,2,LH,luteinizing hormone,,,
precautions,2F44755A-2661-475D-83C5-8923101EB7A3,6/13/2007,1,VMA,vanillylmandelic acid,,,
precautions,0018861f-1b9b-431b-84ee-9d34aab615c3,6/25/2012,5,FSH,follicle-stimulating hormone,,,
precautions,0018861f-1b9b-431b-84ee-9d34aab615c3,6/25/2012,5,LH,luteinizing hormone,,,
precautions,2DBA6C8E-3C51-4762-AE27-DCD760783F9B,11/5/2008,2,TFMA,4-trifluoromethylaniline,,,
precautions,aa756b80-11eb-4f67-abb8-8babcee728b2,7/8/2010,4,MPA,mycophenolic acid,,,
precautions,946cd61f-d733-4edf-96b7-f5566c35ae4a,5/21/2010,1,NET,norethindrone,,,
precautions,946cd61f-d733-4edf-96b7-f5566c35ae4a,5/21/2010,1,EE,ethinyl estradiol,,,
precautions,e3469758-5111-4c30-a7fc-12444e914515,8/31/2010,2,FSH,follicle-stimulating hormone,,,
precautions,e3469758-5111-4c30-a7fc-12444e914515,8/31/2010,2,LH,luteinizing hormone,,,
precautions,8f91e243-7395-4ec9-adf5-37520983daf2,8/18/2006,1,VMA,vanillylmandelic acid,,,
precautions,9de97bb7-36e8-4126-bede-d48375da15df,12/21/2010,6,ODV,O-desmethylvenlafaxine,,,
precautions,61f36cba-e314-4ec9-8c84-5259153049b5,9/2/2009,2,NET,norethindrone,,,
precautions,61f36cba-e314-4ec9-8c84-5259153049b5,9/2/2009,2,EE,ethinyl estradiol,,,
precautions,4256b3c7-23c5-4743-a311-916cee1de1c1,1/25/2012,1,MAOI,monoamine oxidase inhibitors,,,
precautions,4d3531fb-82a4-41ab-8c36-eb0aace61f5c,4/2/2012,3,MAOI,monoamine oxidase inhibitors,,,
specificPopulations,9fd7a181-ab26-4e68-8404-20ce339b0844,9/30/2010,2,DEA,desethylamiodarone,,,
specificPopulations,b7e2af06-1fe4-4b45-ae5d-bc6279ca47f3,6/6/2012,1,DEA,desethylamiodarone,,,
